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LIST OF ABBREVIATIONS 
2-AG    - 2-arachidonoylglycerol 
aCSF    - artificial cerebrospinal fluid 
AEA    - anandamide (N-arachidonoylethanolamide)   
AM251 - N-(piperidin-1-yl)-5-(4-iodophenyl)-1-(2, 4-dichlorophenyl)- 
  4-methyl-1H-pyrazole-3-carboxamide 
AMG9810    - (E)-3-(4-t-butylphenyl)-N-(2,3-dihydrobenzo[b][1,4] dioxin- 
   6-yl) acrylamide 
AMPA    - alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid 
cAMP    - cyclic adenosine monophosphate 
CB1    - cannabinoid receptor type 1  
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ERβ    - estrogen receptor beta 
Ex4    - Exendin-4 
FAAH    - fatty acid amide hydrolase 
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   3a,4,5,9b-tetrahydro-3H-cyclopenta[c]quinolin-8-yl]-ethanon  
GABA    - gamma-aminobutyric acid 
GABAA-R   - gamma-aminobutyric acid receptor type A 
GDP-β-S   - guanosine 5'-[β-thio] diphosphate 
GFP    - green fluorescent protein 
GLP-1    - glucagon-like peptide-1 
GLP-1R   - glucagon-like peptide-1 receptor 
GnRH    - gonadotropin-releasing hormone 
GPCR    - G-protein-coupled receptor 
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GPR30    - G-protein-coupled receptor 30 
GPR54    - G-protein-coupled receptor 54 
GT1-7    - immortalized gonadotropin-releasing hormone neuron cell line 
HEPES -4-(2-hidroxietil)-1-piperazin-etánszulfonsav(4-(2-hydroxyethyl)- 
  1-piperazineethanesulfonic acid) 
HPG axis   - hypothalamo-pituitary-gonadal axis 
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OVLT    - organum vasculosum of the lamina terminalis 
PCR    - polymerase chain reaction 
PF3845    - N-3-Pyridinyl-4-[[3-[[5-(trifluoromethyl)- 
   2-pyridinyl]oxy]phenyl]methyl]-1-piperidinecarboxamide 
PHTPP    - 4-[2-Phenyl-5,7-bis(trifluoromethyl)pyrazolo[1,5-a]pyrimidin- 
  3-yl] phenol 
PPT    - propylpyrazoletriol 
PSC    - postsynaptic current 
RP3V    - rostral periventricular area of the third ventricle 
sGC    - soluble guanylyl cyclase 
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TRPV1    - transient receptor potential vanilloid 1 
TTX    - tetrodotoxin 
vGlut    - vesicular glutamate transporter 
Vrest    - resting membrane potential 
 
DOI:10.15774/PPKE.ITK.2018.010
6 
 
INTRODUCTION 
The survival of species depends on the capability of adaptation and success of reproduction. 
Disorders affecting the units of the reproductive system can result in infertility. In mammals, 
reproduction is controlled by the hypothalamo-pituitary-gonadal axis (HPG axis) [1, 2]. Disorders 
affecting the reproductive axis result in infertility. 
Regulation of the hypothalamo-pituitary-gonadal axis 
There are complex and precisely regulated interactions between the different units of the HPG axis 
via hormone messengers. The HPG axis controls the ovarian cycle, sexual development, maturation 
and aging [1-5]. Gonadotropin-releasing hormone (GnRH; also called luteinizing hormone-
releasing hormone) synthesizing neurons of the hypothalamus form the key central elements of the 
HPG axis [1, 2, 6]. The hypophysiotropic axons of GnRH neurons release GnRH into the fenestrated 
capillaries of the hypophyseal portal circulation in a pulsatile manner [7]. GnRH neurohormone 
reaches its target cells in the anterior pituitary gland via the long portal veins. Here, the episodically 
released GnRH stimulates its receptors on the surface of the gonadotroph cells, that results in a 
rhythmic discharge of gonadotropins, the follicle-stimulating hormone (FSH) and luteinizing 
hormone (LH) [2, 8]. FSH and LH are released into the systemic circulation and act on the gonads: 
FSH stimulates the maturation of ovarian follicles in females, the spermatogenesis in males and 
stimulates gonads to produce steroids. LH stimulates secretion of sex steroids from the gonads in 
both sexes. The gonadal steroids, in turn, exert negative and positive feedback actions on the 
hypothalamus and the pituitary, and regulate the synthesis of GnRH and the two gonadotropins [2, 
9, 10] (Figure 1.). Gonadal steroid hormones also have a number of other important physiological 
effects upon almost all of the organs, including the brain.  
Properties of the GnRH neuronal system 
GnRH neurons play a decisive role in the regulation of the HPG axis and thus, in the control of 
reproduction. In this chapter, the properties and regulation of GnRH neurons will be discussed 
focusing on structural organization of the GnRH system, the operating signaling mechanisms of 
GnRH neurons and the molecular background of information processing. 
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Figure 1. Relationship between the regulatory units of the 
reproductive axis. Hypothalamic GnRH neurons release GnRH 
neurohormone into the hypophyseal portal circulation. Via this 
portal system GnRH reaches its target cells in the anterior 
pituitary and regulates the synthesis and secretion of the 
gonadotropins, such as follicle-stimulating hormone (FSH) and 
luteinizing hormone (LH). FSH and LH are released into the 
systemic circulation and act on the gonads to stimulate gonadal 
steroid secretion. Sexual steroid hormones, such as estrogen (E), 
progesterone (P), and testosterone (T) influence the 
hypothalamic and pituitary hormone secretions via feedback 
loops. Abbreviation: median eminence (ME). 
 
 
The gonadotropin-releasing hormone 
GnRH molecule was discovered in 1971 by Roger Guillemin and Andrew Schally [11]. Since the 
original discovery, different forms of GnRH have been found in vertebrates. GnRH-l is a 
decapeptide (pyroGlu-His-Trp-Ser-Tyr-Gly-Leu-Arg-Pro-Gly-NH2). The gene encoding GnRH1 is 
on chromosome 8. GnRH-1 is a neurohormone, the hormone itself is synthetized in specific neurons 
of olfactory placode origin and is released at their terminals. The hypophysiotropic GnRH-1 
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population regulates the synthesis and release of pituitary gonadotropins [12]. The GnRH-1 
neurosecretory system and the structure of GnRH-1 are evolutionarily conserved in vertebrates. In 
all mammals the amino acid sequence of GnRH-1 is the same [12]. The scope of this dissertation 
has been the hypophysiotropic GnRH-1 neurons (hereafter GnRH) and their involvement in the 
regulation of the HPG axis. 
There are two additional GnRH molecules that form distinct populations in the brains of several 
species. GnRH-2 and GnRH-3 differ at several amino acids from GnRH-1. GnRH-2 is often referred 
to as chicken GnRH and GnRH-2 neurons are present in the midbrain tegmental area [12]. GnRH-
3 can be found in the telencephalon of fish, amphibians and some mammals. This hormone is 
sometimes referred as salmon GnRH [12].  
The development, distribution and structural properties of GnRH neurons  
The GnRH neurons originate from the olfactory placode and migrate into the forebrain along the 
olfactory-vomeronasal nerves from the gestational day 11 in mice [13-16]. This phenomenon can 
be observed not only in rodents, but in humans [17], rhesus macaques [18], and chicken [19]. 
Disorders in the migration process can cause hypogonadotropic hypogonadism which is 
characterized by the lack of hypothalamic GnRH neurons in the forebrain leading to reproductive 
deficiencies. The human disease is called Kallmann syndrome, which often coincides with anosmia 
[20]. Migrating GnRH neurons settle down in the hypothalamic/median preoptic area by the  time 
of birth [14]. According to the present literature there are approximately 800 GnRH neurons in the 
rodent brain, 1000-2000 in primates brain and their numbers are equal in both sexes [21-24]. 
Surprisingly, these small amount of GnRH neurons are sufficient to carry out the control of 
reproduction [25].  
GnRH neurons have fusiform morphology. The perikarya of the cells are relatively small (10-15 
µm). Being bipolar neurons GnRH cells have two processes emerging from the cell body: two 
dendrites or one dendrite and one axon. However, sometimes axon emanates from one of the main 
dendrites [26-28].  
GnRH neurons form anatomical and functional networks. Communication among the cells is mainly 
achieved through axo-somatic and axo-dendritic connections [29], however other types of 
communication have also been observed. Some studies showed tight junctions between GT1-7 
immortalized GnRH neurons [30]. The other connection type observed between GnRH nerve cells 
is formed by continuous intercellular bridges, where the cytoplasmic domains communicate with 
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each of them [31, 32]. These connections between GnRH neurons have a crucial role in the 
regulation of the synchronized operation of the system.  
 
 
 
Figure 2. Distribution of the GnRH neurons in mice. 
Sagittal (top) and coronal (bottom) views of the distribution 
of GnRH neuron cell bodies (black dots). These neurons 
located mainly in the diagonal band of Broca (dbb), medial 
septum (MS) and the preoptic area (POA). Abbreviations: 
anterior commissure (ac); median eminence (ME); optic 
chiasm (oc); organum vasculosum of lamina terminalis 
(OVLT). The figure is based on the image of Dr. Michel 
Herde [33]. 
 
 
GnRH neurons are located in a relatively broad area in the brain. In rodents GnRH cells show a 
scattered distribution pattern, these neurons are located principally in the medial septum, the 
diagonal band of Broca, the medial and rostral preoptic area, in the vicinity of the organum 
vasculosum of the lamina terminalis (OVLT) [34, 35] (Figure 2.).  
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The efferent projections of the GnRH neurons 
The major efferent targets of the GnRH neurons are two circumventricular organs: the median 
eminence (ME) and the organum vasculosum of lamina terminalis (OVLT) [15, 16]. The ME is a 
functional interface between the hypothalamus and the anterior pituitary gland. Hypothalamic 
neurons release peptides and small molecule neurotransmitters into portal vessels. The walls of the 
capillaries are fenestrated to ensure maximal hormone permeability, the axons of hypophysiotropic 
neurons terminate around this capillary network. The portal capillaries are reunited forming the long 
portal veins [36]. The ME has three parts: the ependymal layer, the internal zone and the external 
one. From 50% to 70% of all GnRH axons terminate in the external zone of the ME where GnRH 
is released into the portal capillaries in a pulsatile manner [7, 9, 37].  
Besides the hypophysiotropic axon projections, GnRH fibers also innervate the OVLT. The OVLT 
is another sensory circumventricular organ of the brain, located along the ventral part of the anterior 
wall of the third ventricle [38]. It is made up of neurons, glial cells and ependymal cells. The 
ependymal cells form tight junction connections near their apical surfaces, which avert the free flow 
of the cerebrospinal fluid from the ventricle into the brain parenchyma. Being a circumventricular 
organ, OVLT contains a rich vascular network containing specialized fenestrated capillaries [38]. 
Multiple projections of GnRH neurons in the region of the OVLT and ME permit the sensing of 
peripheral signals due to the lack of the blood-brain barrier here [38]. 
There are less studied extrahypothalamic GnRH axon projections in addition to the above-
mentioned ones in several areas of the brain. Although these cells make up 30 percent of all GnRH 
neurons, these non-hypophysiotropic GnRH cells and projections are rarely investigated [7]. A 
recent study showed that this kind of GnRH neurons communicate with approximately 50,000 
neurons in 53 functionally diverse brain areas [39]. Moreover, a significant number of GnRH 
neurons are located in the medial septum and the olfactory tubercle, which innervate the olfactory 
bulb [35]. This suggests that the GnRH system may have a role in the transmission or modulation 
of olfactory stimuli, which is closely related to some reproductive functions and behavior [39].  
Regarding the specific phenotype of GnRH efferent system, it has been shown that GnRH neurons 
express mRNA of vesicular glutamate transporter-2 (vGlut2) in rats [40]. This vesicular transporter 
is obligatory for accumulating glutamate into synaptic vesicles, thus it indicates that GnRH neurons 
are glutamatergic suggesting the possibility that GnRH neurons could release glutamate from their 
nerve terminals. Nevertheless, recently it has been also demonstrated that a subset of GnRH neurons 
is GABAergic in the mouse brain [41] indicating the chemical heterogeneity of GnRH neurons. 
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Synaptic regulation of GnRH neurons  
One of the most significant regulatory neurotransmitters in the central nervous system, as well as in 
the hypothalamus, is γ-aminobutyric acid (GABA). GABA is the main neurotransmitter acting on 
GnRH neurons [42], as major proportion of synaptic contacts on GnRH neurons is GABAergic [43]. 
GnRH neurons express the ionotropic GABAA [44-46], and the metabotropic GABAB [47] 
receptors. The observed GABAA receptor-mediated postsynaptic currents [45, 46] also confirm the 
GABAergic input to these neurons. Although GABA is usually an inhibitory neurotransmitter in 
the adult central nervous system, early data seemed controversial whether GABA stimulates [45, 
48] or inhibits [49] GnRH neurons. Now, it has been widely accepted that most mature GnRH 
neurons are excited by GABA [50-52]. The intracellular chloride ion concentration is responsible 
for determining the polarity of GABA response [53]. The hyperpolarizing (generally inhibitory) 
action of GABA exists when intracellular chloride ion concentration is low whereas the depolarizing 
(generally excitatory) action of GABA occurs when intracellular chloride ion concentration is high, 
such as in GnRH neurons. The excitation by the GABAA receptor activation is due to the high 
intracellular chloride level of GnRH neurons. On one hand this high intracellular chloride level is 
due to the absence or low expression levels of the K-Cl cotransporter 1 in GnRH neurons. This 
cotransporter excludes chloride ion from the cytoplasm in neurons. On the other hand high 
expression of the Na-K-Cl cotransporter 2 in GnRH neurons is responsible for maintaining high 
chloride level in GnRH neurons, since this cotransporter mediates inward transport of chloride ion 
[45]. GABAA receptor is a ligand-gated chloride channel. Activation of this receptor leads to the 
opening of the channel and results in chloride ion efflux and neuronal depolarization in GnRH 
neurons. 
As mentioned above GnRH neurons also express the metabotropic GABAB receptor [47, 54].  The 
functional GABAB receptor is a G-protein-coupled receptor linked to potassium channels or even 
calcium channels [55]. The receptor is a heterodimer formed by a GABA B1 and B2 subunit. 
Activation of GABAB receptors triggers inhibitory postsynaptic currents leading  to reduced 
neuronal excitability of GnRH neurons [55]. GABA exerts its inhibitory effect via GABAB receptors 
on GnRH neurons [47, 56].  
The major GABAergic innervation of GnRH neurons is supposed to arise from local GABAergic 
interneurons [10]. GABAergic inputs play major roles in the mediation of metabolic  [46], circadian 
[57] and estrogen [58] signals to the GnRH system [57].  
Another major neurotransmitter in the afferent control of GnRH cells is glutamate [59]. The markers 
of glutamate-secreting nerve terminals are the vesicular glutamate transporters (vGlut1, vGlut2 and 
DOI:10.15774/PPKE.ITK.2018.010
12 
 
vGlut3). GnRH neurons receive synapses from vGlut2 containing glutamatergic neurons and these 
inputs were observed mostly on the dendritic compartment of GnRH cells [59]. Consistent with this, 
GnRH neurons express all ionotropic glutamate receptors, the alpha-amino-3-hydroxy-5-methyl-4-
isoxazole propionic acid/kainate (AMPA/KA) and N-methyl-d-aspartate (NMDA) receptors [44, 
58, 60]. Whereas GABAA receptor mediated postsynaptic currents can be easily detected in all 
GnRH neurons, not all neurons exhibit postsynaptic currents mediated by these glutamate receptors 
[58, 60].  However, it should be noted that currents generated on the distal dendrites might be 
insufficient to be detected on the perikaryon [27], but may still have important role in the cell 
function. Whole-cell patch clamp studies reveal that glutamate transmission predominantly 
mediated by AMPA/KA receptors, but NMDA mediated postsynaptic currents were also observed 
in GnRH neurons [44, 58].  Activation of these ionotropic glutamate receptors contributes to the 
pulsatile [61] and also to the  surge [62] release of GnRH.   
In addition to the fast neurotransmission, slower glutamatergic neuromodulation is also present in 
GnRH neurons, for which metabotropic receptors are responsible. Metabotropic glutamate receptors 
(mGluRs) are G-protein-coupled receptors (GPCRs). These can be grouped into three groups 
(Group I, II and III). Group I mGluRs are localized postsynaptically on neurons or glial cells. 
Activation of these receptors increases intracellular Ca2+ level. The presynaptically localized Group 
II/III mGluRs mediate feedback inhibition [63]. Bath application of Group II/III mGluR agonists 
decreased the frequency of GABAergic events on GnRH neurons. The mGluRs responsible for this 
synaptic inhibition are suggested to be located on the presynaptic GABA terminals and not on the 
GnRH neurons themselves [64]. 
The main electrophysiological properties of GnRH neurons 
Our experiments were performed on GnRH-green fluorescent protein (GFP) transgenic mice, in 
which GnRH promoter is linked to a green fluorescent reporter molecule, allowing the microscopic 
detection of GnRH neurons in slices preparations [65], as the expression of the reporter is restricted 
to these neurons. Thus, GnRH neurons were visualized using fluorescence microscopy and the 
identified individual neurons were used for electrophysiological recordings and subsequent 
structural, molecular analysis. It is important to note that the main electrophysiological properties 
of GFP expressing GnRH neurons [44, 65], do not differ from the wild type cells using either brain 
slices [66], primary cell cultures [66, 67] or immortalized GnRH neuronal cell line (GT1) [68, 69].  
Resting membrane potential (Vrest) ranges approximately -55 to -65 mV in GnRH-GFP cells [44, 
65].  The input resistance shows the integrity of the cell, reflects the extent to which membrane 
DOI:10.15774/PPKE.ITK.2018.010
13 
 
channels are open. Under physiological conditions the input resistance of GnRH neurons is high, 
approximately 1.60 GΩ [65]. This means that these cells have relatively few channels open at the 
resting membrane potential.  The high input resistance also indicates that small currents can have a 
large impact on membrane potential.  
GnRH neurons present periodic, spontaneous action potentials which could be blocked by 
tetrodotoxin (TTX) indicating that these are mediated by voltage-gated sodium channels [65] 
because TTX can inhibit the firing of action potentials by binding to voltage-gated sodium channels. 
The episodic, not continuous firing means that GnRH neurons showed quiescent periods with 
intermittent action potentials [65, 66]. The spontaneous action potentials were observed with an 
amplitude of >60 mV (76.9 ± 5.5 mV) [65].  
Based on the firing patterns of adult GnRH neurons there are three different populations observed 
in acute brain slices. Cell-attached recordings revealed that majority of the GnRH neurons exhibit 
burst firing (∼65%), another population remains silent, and the last one is a smaller group exhibiting 
continuous activity. Note that, in vivo experiments showed that only ∼15% of GnRH neurons 
exhibit burst firing in mice [70]. These heterogenous firing patterns are observed in both 
gonadectomized and intact male and female mice. [66].  
GnRH neuron-related feedback mechanisms in reproduction 
The delicate balance of coordinated signals among the hypothalamus, pituitary gland and the gonads 
is strongly related to the precise function of GnRH neurons. The pattern of GnRH release forms the 
final output signal of the hypothalamus towards the pituitary gland. Thus, the secretion of 
gonadotropins (LH, FSH) from the anterior pituitary gland is influenced by hypothalamic GnRH 
pulse frequency and amplitude. GnRH pulses occur every 30-90 minutes and both the frequency 
and amplitude are crucial for normal gonadotropin release [9]. Low GnRH pulse frequency is 
required for FSH production and release, whereas high GnRH pulse frequency stimulates LH 
synthesis and release [9]. Furthermore, pulsatile GnRH secretion is indispensable to prevent the 
desensitization of GnRH receptors and thus to maintain the hormone sensitivity of neurons of the 
pituitary gland. Gonadotropins activate gonadal steroid hormone synthesis and these gonadal 
steroids exert negative (in both females and males) or positive (exclusively in females) feedback 
actions on the central components of the HPG axis (Figure 1.).  
The negative feedback loop is the common regulatory mechanism in both sexes. In males sex 
steroids suppress GnRH neuron activity and GnRH release. After puberty, the testicular hormone 
genesis is continuous. FSH stimulates the spermatogenesis, while LH stimulates Leydig cells in 
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testes to produce testosterone. High levels of androgens exert a constant, direct/indirect inhibitory 
action on the hypothalamic GnRH neurons and pituitary via acting on the androgen receptors [71]. 
The GnRH and LH are secreted in pulsatile manner in males [72]. The orchidectomy of male 
animals and the testosterone treatment in females during the so-called critical postnatal period 
(postnatal day 5-10) has demonstrated that testosterone surge is responsible for the development of 
sexual dimorphism [73], including in brain structures. Consequently, testosterone and estrogen 
(which originates from testosterone by aromatase enzyme) have constant inhibitory effect on the 
reproductive axis through the androgen and estrogen receptors, respectively in adult rodents. The 
positive feedback does not occur in mature male animals. 
Female animals have a cyclic pattern of reproductive function which is called estrus or ovarian 
cycle. A cycle lasts four days in mice and is characterized by four stages: proestrus, estrus, metestrus 
and diestrus. The pattern of GnRH and gonadotropin release and thus blood estrogen levels vary 
throughout the different stages. During the major part of the ovarian cycle (throughout the estrus-
diestrus phase) the relatively low level of estrogen (approximately 10 pM) exerts negative feedback 
effect on the hypothalamus and pituitary. This means estrogen reduces GnRH pulse amplitude and 
frequency, leading to the suppression of LH release in the pituitary, thereby, repressing its own 
follicular synthesis [8, 74]. The negative feedback action of estrogen is modulated by peptides 
produced by the ovaries such as inhibin A, inhibin B, activin or follistatin [75, 76]. 
In proestrus, mature follicles show a dramatic increase in their estrogen secretion and a modest 
elevation in progesterone production. The response to this sustained elevating estradiol level is 
involved in the switch from negative to positive feedback in the hypothalamus. The positive 
feedback effect of estradiol initiates GnRH surge, a large increase in the volume of GnRH release 
[57, 77]. This can be explained by a fold elevation of amplitude and frequency of the GnRH 
secretory pulses [78]. Meanwhile, the responsiveness of the gonadotropin cells to GnRH increases 
[79] causing a surge in LH release from the anterior pituitary gland, initiating ovulation in the ovary 
[8, 77].  
Classical and non-classical estrogen receptor signaling pathways 
Estrogens in females are produced primarily by the ovaries, but the whole enzyme set is also 
expressed in neurons and astrocytes for estrogen synthesis in the central nervous system [80]. Sex 
steroids, including the three major natural estrogen  – estrone (E1), estradiol (E2) and estriol (E3) – 
all derive from cholesterol through different steps of enzymatic reactions [80]. The major product 
from the whole biosynthesis process is the 17β-estradiol (E2) and it is the primary biologically 
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active and prevalent form of estrogen. E2 is produced by aromatase from testosterone or is converted 
from estrone at the end of the biosynthesis process [81]. E2 is one of the principal regulators of 
GnRH cells and acts as a classic, homeostatic feedback molecule between gonads and brain. 
Estradiol is critical in controlling GnRH neurons to exhibit fluctuating patterns of biosynthetic and 
secretory activity [10].   
The actions of estrogen on neurons are mediated by estrogen receptors (ER). Estradiol mainly 
interacts with two types of classical estrogen receptors, ERα and the ERβ, each encoded by a 
separate estrogen receptor gene (ESR) 1 and 2, respectively. These receptors belong to the 
superfamily of nuclear receptors [82, 83]. E2 exerts its effect through two major signaling pathways: 
the genomic (classical, nuclear-initiated) signaling [84, 85] and the acute, non-genomic (non-
classical, membrane-initiated) signaling [85-89]. In classical, genomic ER signaling pathway 
estrogen diffuses passively across the cell membrane then binds and activates ERs [82, 83]. 
Activation of ERs leads to a conformational change of the receptors and subsequent receptor 
dimerization. The two receptor types can form ERα (αα) or ERβ (ββ) homodimers or ERαβ (αβ) 
heterodimers. The dimeric receptors enter the nucleus and subsequently bind to the estrogen 
response element on the promoter regions of target genes leading to gene activation or repression 
[82, 83].  
Additionally, estrogen is capable to bind and activate receptors associated with the plasma 
membrane, and thus exerts a rapid, direct effect (non-genomic, non-classical signaling), such as 
rapid increase in cAMP, or altered firing of neurons within seconds [85-89]. Receptors that are 
responsible for rapid action of estrogen are called extranuclear ERs.  These ERs are associated with 
signaling complexes in the plasma membrane [90]. Most of the rapid effects of estrogen can be 
induced by selective ERα or ERβ agonists [91] or antagonized by the ER antagonists [92]. The rapid 
effects of estrogen are absent in ER mutant animals, since estrogen had no effect on an important 
target of the rapid estrogen action: the cyclic adenosine monophosphate (cAMP) response element 
binding  protein (CREB) phosphorylation in double ERαβKO mice [93]. In addition to ERα and 
ERβ, other types of membrane associated receptors might also participate in the rapid estrogen 
effects, such as G-protein-coupled receptor 30 (GPR30) found in primate [94] and mouse [95] 
GnRH neurons. 
Influence of estrogen on functions of GnRH neurons 
Rapid action of E2 effectively modulates neuronal functions. Several studies have reported the non-
genomic effect of estradiol in GnRH neurons. Estradiol increased the phosphorylation of CREB 
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[89]. The action of estrogen was rapid (<15 min) on CREB phosphorylation, indicating a non-
genomic mechanism [89]. It has also been demonstrated that CREB within GnRH neurons is an 
important target for estrogen negative feedback actions [96]. In addition, estradiol increased calcium 
oscillations [86] and potassium currents [97-99] in GnRH neurons. ERβ has a role to play in 
mediating acute estrogen actions. Moreover, an in vivo study revealed that GnRH neurons respond 
to estrogen in a rapid manner through an ERβ-dependent mechanism in the mouse [89]. 
Nevertheless, the role of ERβ in GnRH neuron function is far from the fully elucidated. 
Regarding the rapid effect of low physiological estradiol levels, it has been demonstrated, that 
estradiol (10 pM) inhibited GnRH neurons firing in a rapid manner when the fast synaptic GABA 
and glutamate receptors were left intact [100]. This indicates the involvement of fast 
neurotransmission in the rapid effect of estradiol and suggests an effect upstream of GnRH neurons. 
As mentioned above, E2 can inhibit (negative feedback) or stimulate (positive feedback) GnRH 
release, which depends on estradiol concentration and the physiological state of the body. Estradiol 
feedback mechanisms alter the synaptic transmission to GnRH neurons and their intrinsic 
excitability [45, 100, 101]. The way that estradiol changes GnRH neuron functions is different in 
the two feedback mechanisms. During positive feedback action high physiological (preovulatory) 
concentrations of estradiol (approximately 100-200 pM in rodents) has a great influence on GnRH 
neurons and pituitary gonadotrophs to generate the preovulatory LH surge [8, 10, 57, 77]. According 
to a popular hypothesis, positive steroid feedback is achieved via presynaptic interneurons that are 
estradiol-sensitive. Estradiol may act via various ERs, mainly the ERα and ERβ. These receptors 
can act either on the DNA as transcription factors [84, 85] or estradiol is able to initiate membrane-
associated signaling cascades via membrane-associated receptors [85-89].  
One of the estradiol-sensitive presynaptic systems acting upstream the GnRH neurons during 
positive feedback is the kisspeptin (KP) neuron system. A population of KP neurons form a compact 
nucleus in the rostral periventricular area of the third ventricle (RP3V) in the mouse brain. The 
RP3V population is proposed to mediate the positive feedback of estrogen [85]. This is indicated 
by the fact that administration of KP shows a profound increase in serum gonadotropin levels via 
the stimulation of the secretory activity of GnRH neurons [102]. KP is the endogenous ligand of G-
protein coupled receptor 54 (GPR54) [103]. GPR54 is highly expressed in GnRH neurons [102]. 
Mutations of KP [104] and GPR54 [105] cause hypogonadotropic hypogonadism with partial or 
moderate puberty in humans, while over activation of this system causes puberty praecox [106]. 
The direct effect of KP-producing neurons on GnRH neurons is supported by numerous 
observations. It was shown that KP axons innervate the perikaryon and dendrites of GnRH neurons 
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[107] and they respond to KP with increased neuronal activity [108]. The RP3V population has role 
in estrogen positive feedback [85], as KP neurons that contact GnRH neurons have been shown to 
express ERα and these neurons in the RP3V release KP in response to estrogen action [85].  
During negative feedback mechanism low physiological level of estradiol (~10 pM) represses 
gonadotropin secretory activity in females by inhibiting hypothalamic GnRH secretion [10, 100]. 
Changes in the function of GnRH neurons are thought to be mediated by estradiol-sensitive afferents 
at this stage of the cycle, and the population of KP neurons located in arcuate nucleus are defined 
as the main regulator of estrogen negative feedback [85, 109]. ERα was detected exclusively in 
various synaptic afferent systems such as KP neurons of arcuate nucleus regulating GnRH neurons, 
but importantly GnRH neurons themselves do not express this receptor type [109-114]. Thus, the 
regulation of the negative feedback is more complex, several brain regions, cell types, and estrogen 
receptors could be involved in suppressing the activity of GnRH neurons. The important fact that 
GnRH neurons express the ERβ [112, 115-117] as a direct target of estradiol feedback further 
increases complexity of this system. 
Data in the literature seems to be controversial regarding the role of the ERβ in the negative 
feedback. Experiments from female mice of different ERβKO mutant mouse lines [118-120] 
showed a range of reproductive phenotypes from mild subfertility [119] to complete infertility 
[120]. Examinations in global ERKO mice have shown the importance of ERα, and possibly ERβ, 
in reproductive regulation [113]. However, investigations in global knockout mice do not allow to 
make conclusions on a fine scale, and effects could be compensated by unknown mechanisms. In 
addition, neuron-specific deletion of ERα and ERβ in mice suggested that ERα seems to be essential 
for acute E2 negative feedback while ERβ particularly in GnRH neurons appears to be less critical 
[110]. These data suggest that ERβ may not be critical for central estradiol negative feedback of the 
HPG axis. In contrast, gonadotropin levels are less increased in ERα knockout versus the double 
(ERαβ) knockout mice, indicating that ERβ may still have a role in negative feedback of the HPG 
axis [121]. In addition, the exclusive role of the ERα in the negative feedback is questioned by a 
recent study in which KP-ERα knockout mice failed to show LH surges in response to estradiol but 
retained responsiveness to the negative feedback effects of estradiol [111]. Homozygous ERβKO 
female mice demonstrated subnormal fertility and had slightly elevated basal LH levels which 
suggests defective estrogen negative feedback [122]. These results indicate that estrogen negative 
feedback actions can be mediated by mechanisms that are independent of ERα and thus these other 
pathways may normally function as parts of the negative feedback mechanism. The fact that the 
ERβ is expressed in GnRH neurons suggests the physiological relevance and raises the possibility 
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of the direct role of the ERβ in feedback regulation. Thus, in this dissertation, I define one of the 
mechanisms present in negative feedback of E2. 
 
Metabolic signals 
Reproduction is an energy-demanding process which is related to the metabolic state of the body. 
The reproductive success of an individual is tightly linked to the nutritional state. Both obesity and 
malnutrition have been reported to disrupt reproduction. This means, if the correct utilization of 
metabolic resources is not ensured (as in the case of anorexia nervosa), or on the contrary, if there 
is a constant energy surplus available (such as obesity) the body must serve its priorities to obtain 
the physiological state ensuring survival. For instance, neuronal activity or blood circulation cannot 
be compromised, whereas thermoregulation, or growth can be reduced in a somewhat wider scale 
in metabolic stress. 
This reproductive-metabolic connection requires a coordinated action of many central and 
peripheral regulators. Changes in energy homeostasis trigger fluctuations in hormonal (for example 
leptin, insulin and ghrelin) and nutritional (for instance glucose, lipids) signals that feedback mainly 
to the brain regions which regulates metabolism and fertility. These actions modulate function of 
different levels of the HPG axis, enabling the close cooperation between the energy level and 
gonadal function [123] (Figure 3.). However, the effects of metabolic signals on GnRH neurons are 
mostly unknown.  
The adipocyte hormone leptin is a signal of energy sufficiency, suppresses feeding and increases 
energy expenditure [124]. The central effect of leptin was demonstrated by the experiment in which 
leptin receptor was ablated in a forebrain specific manner and as a result of it, mice became obese 
and infertile [125]. However, it was thought that GnRH neurons may not be targeted directly by 
leptin, because there was no conclusive evidence for leptin receptor expression in GnRH neurons 
[125].  Nonetheless, there is also a study in the literature claiming that leptin may act directly on 
GnRH neurons to alter postsynaptic responsiveness to GABA [46]. Nevertheless, there is no doubt 
about the physiological importance of leptin in the regulation of reproductive functions. 
Insulin is another factor which conveys information between metabolic and reproductive system. 
Insulin is a pancreatic peptide hormone produced by beta cells of the pancreatic islets which 
modulates glucose homeostasis and body weight regulation. It has been shown, that neuron-specific 
insulin receptor-knockout mice exhibit hypogonadism [126]. Although insulin receptor is expressed 
in GnRH neurons, activation of it did not trigger any insulin-induced signal transduction pathway 
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such as phospho-Akt or phospho-extracellular-signal-regulated kinase 1/2 in GnRH neurons [127]. 
Another study has presented that specific deletion of insulin receptor in GnRH neurons did not 
modify puberty or fertility [128]. These data suggest that central insulin signaling on reproduction 
is not mediated directly via GnRH neurons. 
In contrast to leptin and insulin, ghrelin is a signal of energy deficiency. Ghrelin is predominantly 
produced by the stomach but ghrelin-expressing neurons have also been detected in  the  central 
nervous system and specifically in the hypothalamus [129]. Several studies have demonstrated the 
negative effect of ghrelin at different regions of the HPG axis. It has been shown that ghrelin is able 
to suppress GnRH pulsatility and gonadotropin release [130]. First, ghrelin acts indirectly on GnRH 
neurons [131], on the other hand, our laboratory has provided evidence for direct inhibitory action 
of ghrelin on GnRH secreting neurons [132]. These studies clearly demonstrated that ghrelin plays 
a pivotal role in suppressing the reproductive axis during low energy conditions. 
Glucagon-like peptide-1 signaling 
Another candidate that responsible for transmitting metabolic information to GnRH neurons is the 
glucagon-like peptide-1 (GLP-1), which is one of the main target molecules of our study. Glucagon-
like peptide-1 was originally described as a gut-derived peptide converted from the preproglucagon 
gene product and secreted from intestinal L-cells in response to food intake [133]. Being an incretin 
hormone GLP-1 is responsible for the control of insulin release following food intake from β cells 
of pancreatic islet in a glucose-dependent manner [134]. The mechanisms of GLP-1 controlling 
energy intake and nutrient assimilation are broad: enhances satiety, reduces food intake [135], 
inhibits gastric emptying [136], and increases insulin secretion in the presence of glucose [134]. 
GLP-1 exerts its biological effects by binding to GLP-1 receptor (GLP-1R), which is a member of 
the class B family of  G-protein-coupled receptors [137]. Activation of this receptor is associated 
with increased intracellular calcium level, inhibition of voltage-dependent potassium currents and 
activation of gene expression through Erk1/2, protein kinase C, and phosphatidylinositol 3-kinase 
signaling pathways. GLP-1R signaling also triggers CREB phosphorylation [134]. GLP-1 and 
Exendin-4 (Ex4) a long lasting agonist of the GLP-1R can cross the blood-brain barrier [138], 
showing the ability to reach various control centers of homeostasis. The GLP-1 is produced not only 
in the periphery but also in neurons of the lower brain stem. These neurons are clustered in the 
nucleus of the solitary tract (NST) and the reticular nucleus of the medulla oblongata [139]. GLP-1 
immunoreactive fibers and terminals were observed in various areas of the brain, for example 
hypothalamus, thalamus, septal regions, cortex and hindbrain (reviewed in: [139, 140]). GLP-1R is 
also widely expressed in numerous brain regions such as in neurons of the circumventricular organs, 
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amygdala, medulla oblongata, superior colliculus, NST, hippocampus, cortex [139], and in 
hypothalamic regulatory centers of glucose homeostasis [141] and feeding behavior [142]. 
In addition to modulating energy homeostasis, a large body of evidence indicates the regulatory 
influence of GLP-1 on reproduction. Intracerebroventricular administration of GLP-1 increased the 
plasma luteinizing hormone level of male rats, and concentration-dependent increase of GnRH was 
verified from cell clusters of immortalized GnRH-producing GT1–7 neurons [143]. GLP-1 doubled 
the amplitude of the preovulatory LH surge, changed the estradiol and progesterone levels leading 
to an increase in the number of mature Graafian follicles and corpora lutea in rats [144]. Experiments 
with male GLP-1R knockout mice showed reduced gonadal weights in males and delayed the onset 
of puberty in females [145].  
 
 
Figure 3. Metabolic factors affecting the hypothalamic regulation of 
reproduction. Under energy deficiency, the secretion of ghrelin by the stomach 
increases, the serum levels of leptin and GLP-1 decreases. Under energy 
sufficiency the GLP-1 production from the intestine rises and the serum level 
of leptin also increases, but ghrelin production by stomach decreases. These 
changes affect the different regions of the hypothalamus leading to modulation 
in the regulation of reproduction. Abbreviations: adipose tissue (at); glucagon-
like peptide-1 (GLP-1); hypothalamus (ht); intestine (it); stomach (st). 
 
Since GnRH neurons are key regulators of the HPG axis, any GLP-1-induced alteration of the GnRH 
neuronal system may have a major impact on reproductive physiology (Figure 3.). Some of the 
intracellular elements of the GLP-1 activated pathway have already been identified [134]. Elevated 
cytoplasmic cAMP level in the GT1–7 cells has been proved [143], but the exact target and detailed 
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molecular mechanism involved in the downstream actions of GLP-1 in GnRH neurons have not 
been elucidated yet. 
The retrograde neurotransmission 
Although GABA is typical inhibitory neurotransmitter in the mature nervous system, GABA is 
excitatory on GnRH neurons via the ionotropic GABAA receptor [50-52]. The activity of GnRH 
neurons is also increased by the activation of ionotropic glutamate receptors [58, 60], therefore, 
these neurons need alternative mechanisms for their inhibitory regulation. Beside the inhibitory 
function of GABAB receptor, the retrograde endocannabinoid signaling can be a candidate to exert 
inhibitory tone on the excitatory afferents, since this machinery is one of the most widespread and 
efficient molecular pathway to control neurotransmitter release probability [146]. 
During a chemical synaptic transmission, a neurotransmitter is released from a presynaptic neuron 
and it diffuses to the postsynaptic neuron. Then the neurotransmitter binds to its receptor on the 
postsynaptic membrane and activates it. The postsynaptic neurons might synthetize and release 
diffusible messenger molecules from their postsynaptic dendrites or cell bodies back to the synaptic 
cleft. Next, the messenger travels “backwards” to the axon terminal of a presynaptic neuron, where 
it activates its receptors located in the membrane of the nerve terminals [146]. Activation of 
retrograde messenger receptors usually causes an alteration in synaptic transmitter release (Figure 
4.) [146]. Retrograde signaling is known to play a role in long-term synaptic plasticity [146, 147]. 
In addition this mechanism has role on the short-term regulation of synaptic transmission [146, 147]. 
Mediators of the retrograde neurotransmission can be classified into different classes: molecules 
derived from lipids (endocannabinoids), gases (nitric oxide), conventional neurotransmitters 
(GABA), peptides (dynorphin), growth factors (brain-derived neurotrophic factor) [147]. Below, 
two of these retrograde molecules are described in more detail: the endocannabinoids and the nitric 
oxide. 
The endocannabinoid system 
The endocannabinoids are endogenous lipid-based messengers. 2-arachidonoylglycerol (2-AG) and 
anandamide (N-arachidonoyl ethanolamine, AEA) are the two most common endocannabinoids 
synthesized and released “on demand” by neurons in the brain. The endocannabinoid signaling 
system consists of two cannabinoid receptors, known as the cannabinoid type 1 and type 2 receptors 
(CB1 and CB2, respectively), their endogenous ligands (AEA, 2-AG) and the synthetizing and 
degrading enzymes that regulate the endocannabinoid synthesis and degradation [148]. Both 
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cannabinoid receptors are activated by all endocannabinoids and they are G-protein-coupled 
receptors. CB1 are abundant in the brain [149], while CB2 is mainly expressed in immune and blood 
cells, although it has been recently found in various brain areas. 
The 2-AG and AEA both are arachidonic acid-containing lipid molecules generated from membrane 
glycerophospholipids, but their biosynthesis is different [148]. The depolarization of the 
postsynaptic cell - through different signaling pathways - leads to the activation of the phospholipase 
C and the generation of diacylglycerol (DAG) from the lipid phosphatidylinositol 4,5-bisphosphate. 
Next, DAG is converted into 2-arachidonoylglycerol by DAG lipase (DGL) [147]. Anandamide 
synthetized together with other N-acylethanolamines in a two-step process of Ca2+-dependent N-
acyltransferase and N-acylphosphatidylethanolamine-hydrolyzing phospholipase D activity [148]. 
Classical neurotransmitters and neuropeptides are stored in vesicles in the neurons. In contrast, 
endocannabinoids are not stored, but synthesized and released in situ from cells, followed by 
immediate action (including tonic one) as signaling molecules (Figure 4.).   
Endogenous and exogenous cannabinoids (such as Δ-9-tetrahydrocannabinol, THC, the main 
psychoactive substance of the Cannabis sativa plant) known to modulate several endocrine 
functions under the control of the hypothalamus, and exert potent negative effects on reproduction 
in many species, like rodents, primates, and humans [150]. Endocannabinoid administration 
inhibited LH secretion from the adenohypophysis and reduced the concentration of sex steroids in 
the blood in both sexes [150]. Expression of CB1 receptors have been described in the 
hypothalamus, including the preoptic area [151], the main location of GnRH neurons [35]. 
Moreover, a previous study from our laboratory showed that the release of 2-AG from GnRH 
neurons caused a reduction in firing rate of GABAergic neurons and as a result a reduced 
GABAergic neurotransmission [152]. 
Various signals can modulate the endocannabinoid signaling in GnRH neurons. Contribution of 
endocannabinoids in GnRH neuron-GABAergic afferent local feedback circuits have been 
demonstrated and these local circuits can be altered by sex steroids [153]. This suggests the putative 
involvement of this retrograde signaling mechanism in the manifestation of feedback effects of 
estradiol on GnRH neurons. Endocannabinoids are also interplay with the modulation of other 
signals, such as metabolic factors. Farkas and colleagues for example showed that ghrelin decreased 
the activity of GnRH neurons in an endocannabinoid dependent manner [132, 154].  
It has been shown that anandamide can also bind to and activate type-1 transient receptor potential 
vanilloid (TRPV1) channels in mammals [155]. The TRPV1 is a nonselective cation channel which 
is wildly expressed in the periphery and in the brain. There is also increasing evidence for the co-
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localization of cannabinoid CB1 and TRPV1 [155]. Moreover, anandamide signaling modulates 
tonic 2-AG signaling via activation of TRPV1 receptors [156], thus, the TRPV1 plays a major role 
in controlling the endocannabinoid pathway. 
The nitric oxide system 
The free radical gas nitric oxide (NO) is another retrograde messenger in the central nervous system. 
The NO is membrane permeant and cannot be stored in neurons, thus it is also synthetized “on 
demand” from L-arginine by nitric-oxide synthase (NOS) [157]. Increased intracellular calcium 
levels trigger a cascade of events leading to NOS activation and NO synthesis. Most of the 
retrograde messenger molecules act via membrane-bound receptors, but since this is a low molecule 
weight gas, the main target of the NO is the soluble guanylyl cyclase (sGC) located in the cytoplasm 
[157]. Guanylyl cyclase catalyzes the synthesis of cGMP from GTP which leads to the activation 
of cGMP-dependent protein kinases (Figure 4.). There are several data about the role of NO in the 
modulation of reproductive axis at various levels, for example NO synthesis increases with the 
follicular development, NO regulates the GnRH synthesis and NO has a modulatory effect on sexual 
behavior [158]. In the central nervous system NOS shows high expression, inter alia, in numerous 
hypothalamic nuclei (for example, suprachiasmatic nuclei, supraoptic nuclei and paraventricular 
nuclei) and also in the diagonal band of Broca in rats [159], where many GnRH neurons are located 
[35]. In rats, the LH surge was inhibited by the blockade of NO synthesis [160]. Similar to these 
experiments using hypothalamic fragments containing the median eminence showed that 
stimulation of NO release increased the release of GnRH [160]. An in vivo study also demonstrated 
the role of NO in the regulation of the hypothalamic centers of reproduction when a NOS inhibitor 
was infused into the preoptic region of female mice. The abolishment of NO synthesis and thus NO 
signaling disrupted the estrous cycle and eventually caused infertility [161]. These data suggest that 
NO plays a fundamental role in the regulation of GnRH neuron. 
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Figure 4.  Schematic illustration of retrograde 2-AG and NO signaling pathways. 
(A) The retrograde 2-AG endocannabinoid signaling. The release of neurotransmitter 
from the presynaptic neuron leads to the depolarization of the postsynaptic neuron 
which results in elevations in intracellular calcium levels through activation of 
ionotropic receptors, and/or voltage-gated calcium channels (VGCC). This leads to the 
activation of PLC, which converts the phospholipid precursor PIP2 into DAG. The 
DAG is metabolized to 2-AG by DGL. 2-AG moves across the synaptic cleft and 
activates the CB1 receptors thereby inhibiting the adenylyl cyclase (AC), then PKA 
which ultimately suppresses the probability of neurotransmitter release. (B) The 
retrograde NO signaling. The neurotransmitter release from the presynaptic neuron 
activates the postsynaptically located ionotropic receptors. This leads to calcium entry 
into the postsynaptic neuron, which activates neuronal nitric oxide synthase (nNOS) to 
produce NO from the NO precursor, L-arginine. The NO moves across the synaptic 
cleft and activates the soluble guanylyl cyclase (sGC), which activates PKG ultimately 
increasing the probability of neurotransmitter release. Abbreviations: 2-
arachidonoylglycerol (2-AG); adenylyl cyclase (AC); cannabinoid receptor type 1 
(CB1); cyclic guanosine monophosphate (cGMP); diacylglycerol (DAG); 
diacylglycerol lipase (DGL); neuronal nitric oxide synthase (nNOS); nitric oxide (NO); 
Phosphatidylinositol 4,5-bisphosphate (PIP2); protein kinase A (PKA); protein kinase 
G (PKG); phospholipase C (PLC); soluble guanylyl cyclase (sGC); voltage-gated 
calcium channels (VGCC). 
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SPECIFIC AIMS 
 
The purpose of my doctoral thesis was to get a more accurate view about the operation of GnRH 
neurons using electrophysiological methods. In the first part of my work, I carried out detailed 
analyses to investigate the mechanisms of the negative estrogen feedback on GnRH neurons. To 
this end, the following essential questions have been raised and studied: 
1. What is the effect of the estradiol on the function of GnRH neurons during the negative 
estradiol feedback period? 
2. Which estrogen receptor is involved in the direct regulatory mechanism? 
3. Does the retrograde endocannabinoid system play a role in the fast action of estradiol on GnRH 
neurons?  If so, what are the molecular constituents and the presynaptic targets? 
In the second part of the dissertation, I present my results about the regulatory role of the metabolic 
hormone glucagon-like peptide-1 (GLP-1). Earlier studies described the modulatory effect of this 
gut hormone on reproduction, although, targets and the involved molecular mechanisms have not 
been elucidated. Therefore, I sought the answers for the following questions: 
1. Does GLP-1 directly affect the functions of GnRH neurons?  
2. Which molecular pathways act downstream to the GLP-1 receptor in the GnRH neurons?   
3. What sort of retrograde signaling mechanism relay the information to presynaptic regulators? 
What are the intermediate components of this regulation? 
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EXPERIMENTAL PROCEDURES 
All the following experiments were carried out with permissions from the Animal Welfare 
Committee of the Institute of Experimental Medicine Hungarian Academy of Sciences (Permission 
Number: A5769-01) and in accordance with legal requirements of the European Community 
(Decree86/609/EEC). All animal experimentation described here was conducted in accord with 
accepted standards of humane animal care and all efforts were made to minimize suffering. 
Attention was paid to use only the number of animals necessary to produce reliable results. 
Experimental animals 
Experiments were performed using adult (postnatal day 50-100), gonadally intact, female or male 
mice from local colonies bred at the Medical Gene Technology Unit of the Institute of Experimental 
Medicine. All mice were housed in the same room under same environmental conditions: animals 
were kept in 12/12h light-dark cycle (lights on at 06:00 h) and temperature controlled environment 
(22±2°C), with standard rodent chow and tap water available ad libitum.  
GnRH-green fluorescent protein (GnRH-GFP) transgenic mice (n=228) bred on a C57Bl/6J genetic 
background were used. In this transgenic animal model, a GnRH promoter segment drives selective 
GFP expression in about 90% of GnRH neurons [65]. Visualization of GnRH neurons using 
fluorescence allows the identification of individual GnRH neurons for electrophysiological 
recordings and subsequent morphological analysis. 
In one part of the experiment series, the gonadal phase of the female animals was important. In mice 
the estrous cycle lasts four days and is characterized as: proestrus, estrus, metestrus, and diestrus. 
These phases can be determined according to the cell types observed in the vaginal smear. Thus, 
the estrus cycle of mice was monitored by checking vaginal smears [162-164] and by visual 
observation of the vaginal opening using recently elaborated method [163, 164]. Metestrous mice 
were then chosen and used for testing how GnRH neurons react for the treatments during the 
negative estrogen feedback period. 
Brain slice preparation and recording 
Mice were decapitated in deep anesthesia by Isoflurane inhalation. All mice were sacrificed between 
9 a.m. and 10 a.m. and all recordings performed between 11 a.m. and 4 p.m. period. After 
decapitation, brain was removed rapidly and immersed in ice cold sodium-free artificial 
cerebrospinal fluid (Na-free aCSF), which had been extensively saturated with carbogen gas, a 
mixture of 95% O2 and 5% CO2. Carbogen gas is indispensable to maintain oxygen saturation of 
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the solutions and the stability of pH value (pH 7). Sodium free solution is needed because the 
synaptic activity should be strongly reduced during slice preparation. In this solution, the low 
sodium concentration reduces presynaptic firing and glutamate release probability which otherwise 
would trigger sodium influx, water intake and subsequent swelling of cells leading to poor survival 
of neurons in the preparation. Thus, the composition of the solution helped to inhibit neuronal 
activity related to the extreme glutamate release and minimizing spontaneous activity and cell death. 
The temperature around the freezing point (2-4 °C) of the solution also contributed to the survival 
of the neurons during the sectioning. The Na-free solution contained the following components (in 
mM): saccharose 205, KCl 2.5, NaHCO3 26, MgCl2 5, NaH2PO4 1.25, CaCl2 1, and glucose 10. The 
osmolarity of the solution was adjusted to 300 mOsm (Osmomat 3000, Gonotec GmbH, Germany).  
Hypothalamic blocks were dissected and 250 μm-thick coronal slices containing the medial 
septum/preoptic area were prepared with a VT-1000S Vibratome (Leica GmBH, Germany) in ice-
cold oxygenated Na-free aCSF. The slices were then transferred into normal aCSF (in mM): NaCl 
130, KCl 3.5, NaH2PO4 1.25, MgSO4 1.2, CaCl2 2.5, NaHCO3 26, glucose 10, osmolarity adjusted 
to 300 mOsm saturated with carbogen gas and were incubated for 1 hour to be equilibrated. 
Electrophysiological recordings were carried out at 33°C, during which the brain slices were 
oxygenated in aCSF with carbogen gas.  Axopatch 200B patch clamp amplifier, Digidata-1322A 
data acquisition system, and pCLAMP 10.4 software (Molecular Devices Co., CA, US) were used 
for electrophysiological recordings. Cells were visualized with a BX51WI infrared-differential 
interference contrast microscope (Olympus Co., Japan) installed on an anti-vibration table 
(Supertech Kft, Hungary).  
Patch electrodes (OD=1.5 mm, thin wall; Hilgenberg GmbH, Germany) were pulled with a Flaming-
Brown P-97 puller (Sutter Instrument Co., CA). The resistance of the patch electrodes was 2–3 MΩ. 
GnRH-GFP neurons in the close proximity of organum vasculosum of the lamina terminalis (OVLT, 
Bregma 0.49-0.85 mm [165]) were identified by brief illumination at 470 nm using an epifluorescent 
filter set, based on their green fluorescence, typical fusiform shape, and characteristic topography 
(Figure 5.) [65]. After control recordings (5 min), the slices were treated with various drugs (see 
below) and the recordings continued for a subsequent 10 min. 
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Figure 5. GnRH-GFP neurons and fibers 
in the organum vasculosum of the lamina 
terminalis. Visualization of GnRH neurons 
using fluorescence permits the 
identification of individual GnRH neurons 
for electrophysiological recordings and 
subsequent morphological analysis. 
Courtesy of Dr. Csaba Vastagh, IEM, HAS 
Laboratory of Endocrine Neurobiology 
 
 
Whole-cell patch clamp experiments 
Currently, the most widely used method for studying the electrophysiological properties of 
biological membranes and the currents that flow through their ion channels is the patch clamp 
technique [166]. In various configurations, this technique permits experimenters to record and 
manipulate the currents that flow either through ion channels or those that flow across the whole 
plasma membrane. Patch clamp technique can even allow low noise measurements of the currents 
passing through a couple of ion channels, by isolating a small patch of the membrane, which 
sometimes can contain solely a single channel. Here, a high-resistance (“giga ohm”) seal is formed 
between the pipette and the membrane of the cell. In the experiments whole-cell configuration of 
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the patch clamp methods was used. This means that the membrane within the pipette is ruptured 
while the gigaseal is still maintained. The main advantage of this method is the ability to manipulate 
of ionic or other composition of the intracellular milieu to aid isolation and detection of 
conductances via specific ion channels. 
During whole-cell patch clamp experiments spontaneous and miniature postsynaptic currents were 
measured. Spontaneous postsynaptic currents (sPSC) are currents generated via mainly by action 
potential dependent presynaptic release of neurotransmitters in the absence of experimental 
stimulation. Miniature postsynaptic currents (mPSC) are currents observed in the absence of 
presynaptic action potentials; they are thought to be the response that is elicited by random release 
of neurotransmitter vesicles. 
The parameters of the measurements were the following: during sPSC and mPSC measurements in 
GnRH neurons the cells were voltage clamped at -70 mV holding potential. The voltage clamp 
technique allows to "clamp" the cell potential at a chosen value, make it possible to measure how 
much ionic current crosses through the membrane of the cell at any given voltage values. Before 
the recording, pipette offset potential, series resistance and capacitance were compensated. Cells 
with low holding current (<50 pA) and stable baseline were used exclusively. Input resistance, series 
resistance, and membrane capacity were also measured before each recording by using 5 mV 
hyperpolarizing pulses. To ensure consistent recording qualities, only cells with series resistance 
<20 MΩ, input resistance >500 MΩ, and membrane capacity >10 pF were accepted. The 
intracellular pipette solution contained (in mM): HEPES 10, KCl 140, EGTA 5, CaCl2 0.1, Mg-
ATP 4 and Na-GTP 0.4 (pH 7.3, osmolarity adjusted to 300 mOsm).  
The postsynaptic current measurements were carried out with an initial control recording (5 min), 
then low physiological concentration of 17β-estradiol (E2, 10 pM), the GLP-1 analog Exendin-4 (1 
µM), the NO-donor L-arginine (1 mM), the selective ERα agonist PPT (10 pM), the selective ERβ 
agonist DPN (10 pM) or the selective GPR30 receptor agonist G1 (10 pM) was added to the aCSF 
in a single bolus onto the slice in the recording chamber and the recording continued for a 
subsequent 10 min.  
When the cannabinoid receptor type 1 inverse agonist AM251 (1 μM), the non-selective estrogen 
receptor antagonist Faslodex (1 µM), the ERβ antagonist PHTPP (1 µM), the NO-synthase (NOS) 
inhibitor L-NAME (100 μM), the GLP-1 receptor antagonist Exendin-3(9-39) (1 μM) or the nNOS 
inhibitor NPLA (1 μM) were used, they were added to the aCSF 10 min before starting the 
experiments and then they were continuously present in the aCSF during the electrophysiological 
recordings. 
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Intracellularly applied drugs, such as diacylglycerol lipase inhibitor tetrahydrolipstatin (THL, 10 
μM), the membrane impermeable G-protein inhibitor GDP-β-S (2 mM), the membrane 
impermeable NO-scavenger CPTIO (1 mM), the transient receptor potential vanilloid 1 (TRPV1) 
antagonist AMG9810 (10 μM), NPLA (1 μM), or the anandamide-degrading enzyme fatty acid 
amide hydrolase (FAAH) inhibitor PF3845 (5 μM) were added directly to the intracellular pipette 
solution. To minimize the spill of the intracellularly applied drugs, the GnRH cells were approached 
rapidly (< 1 min), and the flow rate of aCSF was increased from 5–6 to 8–9 ml/min. Just before 
releasing the positive pressure in the pipette, the flow rate was restored to 5–6 ml/min to avoid any 
mechanical movement of the slice. After achieving whole-cell patch clamp configuration, we waited 
15 min to reach equilibrium in the intracellular milieu before starting recording.  
In the experiments where any spike-mediated release of substances was to be inhibited, firing was 
blocked by adding the voltage-sensitive Na-channel inhibitor TTX (660 nM) to the aCSF 10 min 
before mPSCs or Vrest were recorded. The mPSCs recordings conditions used in our experiments 
were related to the conditions in which GABAA-R activation occurs [46, 152], interestingly this 
GABAergic input via GABAA-R is excitatory on GnRH neurons [50, 167, 168]. Nevertheless, it is 
important to note that GABA inhibits GnRH neurons via GABAB-receptors [50, 169]. 
Resting potentials were recorded using current-clamp method. The current clamp technique records 
the membrane potential while injecting current into the cell through the recording electrode. This 
shows us the cell response when electric current enters the cell, therefore how neurons respond 
to substances that act by opening membrane ion channels. Vrest measurements were carried out at 0 
pA holding current. 
Loose-patch clamp experiments 
In this type of recording, the pipette is pushed to the membrane not tightly but loosely without the 
formation of a tight gigaseal connection, and there is no direct exchange of cytoplasm and 
intracellular fluid. The action currents, which underlie action potential firing, can be recorded with 
this configuration. The advantage of the loose-patch technique is that the composition of the 
cytoplasm is not influenced, and the activity pattern of a cell can be observed for long time (even 
for hours) without changing the intracellular milieu. These experiments were carried out at 33 °C, 
pipette potential was set at 0 mV, pipette resistance 1–2 MΩ, and resistance of loose-patch seal 
varied between 7–40 MΩ. The composition of the pipette solution mimicking the extracellular 
milieu that contained the following (in mM): NaCl 150, KCl 3.5, CaCl2 2.5, MgCl2 1.3, HEPES 10, 
and glucose 10 (pH 7.3, osmolarity adjusted to 300 mOsm). Measurements were carried out with 
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an initial control recording (5 min), then E2 (10 pM) or Exendin-4 (100 nM – 5 μM) was added to 
the aCSF in a single bolus onto the slice in the recording chamber and the recording continued for 
a subsequent 10 min.  In experiments to investigate the involvement of the GLP-1 receptor, its 
antagonist Exendin-3(9-39) (1 μM) was added to the aCSF 10 min before adding Exendin-4. The 
antagonists were continuously present in the aCSF during the electrophysiological recording. 
 
Chemicals and reagents  
Table 1. The chemicals, agonists and antagonists used 
Name Effect 
Concent
ration 
Producer, 
Cat. No. 
References 
17β-estradiol 
(E2) 
non-selective 
estrogen receptor 
agonist 
10 pM Sigma, MO, US 
# E2758 
[8, 100, 170] 
AM251 
cannabinoid receptor 
type-1 inverse agonist 
1 μM Tocris, UK 
# 1117 
[132, 152, 156] 
AMG9810 
transient receptor 
potential vanilloid 1 
antagonist 
10 μM Sigma, MO, US 
# A2731 
[171-173] 
CPTIO 
 
 
nitric oxide scavenger 
 
1 mM Sigma, MO, US 
# C221 
[174, 175] 
DPN 
selective estrogen 
receptor β agonist 10 pM 
Tocris, UK 
# 1494 
To keep 
comparability, all 
ER agonists were 
used at the same 10 
pM concentration. 
Exendin-3(9-39) 
GLP-1 receptor 
antagonist 
1 μM Tocris, UK 
# 2081 
[176-178] 
Exendin-4 
GLP-1 receptor 
agonist 
100 nM – 
5 μM 
Tocris, UK 
# 1933 
[176-178] 
Faslodex (ICI 
182,780) 
non-selective estrogen 
receptor antagonist 
1 µM Tocris, UK 
# 1047 
[100, 152] 
G1 
selective GPR30 
receptor agonist 10 pM 
Tocris, UK 
#3577 
To keep 
comparability, all 
ER agonists were 
used at the same 10 
pM concentration. 
GDP-β-S G-protein inhibitor 2 mM Sigma, MO, US 
# G7637 
[179-181] 
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L-arginine nitric oxide donor 1 mM 
Sigma, MO, US 
#  A8094 
[174, 182] 
L-NAME 
nitric oxide synthase 
inhibitor 100 μM 
Sigma, MO, US 
# N5751 
[174, 183] 
NPLA 
neuronal nitric oxide 
synthase inhibitor 1 μM 
Tocris, UK 
# 1200 
[184-186] 
PF3845 
fatty acid amide 
hydrolase inhibitor 
5 μM Sigma, MO, US 
# PZ0158 
           [156] 
PHTPP 
selective estrogen 
receptor β antagonist 1 µM 
Tocris, UK 
# 2662 
[187, 188] 
PPT 
selective estrogen 
receptor α agonist 10 pM 
Tocris, UK 
# 1426 
To keep 
comparability, all 
ER agonists were 
used at the same 10 
pM concentration. 
THL (tetrahydro- 
lipstatin/orlistat) 
diacylglycerol lipase 
inhibitor 
10 μM Tocris, UK 
# 3540 
[132, 152] 
 
TTX 
(tetrodotoxin) 
selective blocker of 
voltage sensitive Na+ 
channels 
660 nM 
Sigma, MO, US 
# T8024 
[132, 152] 
 
 
Real-time PCR detection of Glp1r and Nos1 in GnRH neurons 
Using patch-clamp technique, the electrical properties of neurons can be studied. Nevertheless, it 
also enables harvesting mRNA from a single neuron to study gene expression at the single-cell level.  
Collecting mRNA for RT-PCR from neurons is a well-established method, including GnRH neurons 
[66, 189-193]. In our study, the mRNA content of individual GnRH neurons of male mice was 
harvested using sterile patch clamp pipette. Patch pipettes were pulled from capillaries sterilized at 
180° C for 6 h and filled with sterile intracellular pipette solution.  The solution consisted of the 
following chemicals (in mM) HEPES 10, K-gluconate 130, KCl 10, NaCl 10, EGTA 1 and MgCl2 
0.1 (pH 7.3, osmolarity adjusted to 300 mOsm). The resistance of the patch electrodes was 2–3 MΩ. 
Harvesting of mRNA samples from GnRH-GFP neurons of acute brain slices was carried out in 
carbogen saturated aCSF at 33°C. After achieving the whole-cell patch clamp configuration, the 
cytoplasm was harvested by applying gentle negative pressure under visual control with extra care 
to avoid any glial RNA contamination with the protocol suggested by Fuzik et al. [194]. 
Cytoplasmic samples were collected by breaking the pipette tip into PCR tubes kept on dry ice [132, 
195].  
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The subsequent PCR detection of Glpr1 and Nos1 RNAs (including cDNA synthesis, pre-
amplification and real-time PCR) were done by my fellow colleague Csaba Vastagh. Briefly, ViLO 
SuperScript III cDNA reverse transcription (RT) kit (Thermo Fisher Scientific, MA, US) was used 
to reverse transcribe the cytoplasm directly in 20 μl reactions.  The intracellular pipette solution was 
used as negative control. The resulting cDNA was used as template for the subsequent pre-
amplification reaction using the Preamp Master Mix kit (Thermo Fisher Scientific, MA, US) 
according to the manufacturer’s protocol. The pre-amplification products were then used in a 1:10 
dilution (in 0.1x TE buffer) before use in qPCR. Real-time PCR was carried out using inventoried 
TaqMan gene expression assays (Thermo Fisher Scientific, MA, USA) using the following primers: 
Gnrh1 (assay ID: Mm01315604_m1), Glp1r (Mm00445292_m1), Nos1 (Mm01208059_m1), glial 
fibrillary acidic protein (GFAP) (Mm01253033_m1) and a housekeeping gene Gapdh 
(Mm99999915_g1). Each assay contained of a FAM dye-labeled TaqMan MGB probe and two 
primers. qPCR conditions were as follows: 2 min at 50 °C and 20 sec at 95 °C, followed by 40 
cycles of 3 sec at 95 °C and 30 sec at 60 °C using the ViiA 7 real-time PCR platform (Thermo 
Fisher Scientific). All cDNA samples were checked for GFAP mRNA expression and only GFAP-
negatives were used in the analysis of the expression of Nos1 in order to avoid glial contamination. 
In order to successfully detect Glp1r in RT-PCR experiments, three pooled samples from three mice 
were used. Each pooled sample contained cytoplasm of 10 GnRH neurons. Individual GnRH 
neurons were used (a total number of 30 separated neurons from five animals) to investigate Nos1 
expression. 
Statistical analysis 
Each experimental group contained 8–18 recorded cells from six to nine animals in the 
electrophysiological measurements. Responding cells in the E2-related experiments were defined 
according to definition of Chu et al. [100] with slight modification: cells were considered as 
responding ones if any negative change was detected in their frequency. Recordings were stored 
and analyzed off-line. Mean firing rate, sPSC and mPSC frequency were calculated as number of 
spikes divided by the length of the respective period (5 min “baseline value” and 10 min “agonist 
period”, respectively). In GLP-1-related experiments bursts were defined according to Lee et al. 
[196]. In these experiments burst frequency was calculated by dividing the number of bursts with 
the length of the respective period. Intraburst frequency calculated by dividing the number of spikes 
with the length of the respective burst. Percentage changes resulted from drugs were calculated by 
dividing the value to be analyzed before (5 min) and after (the subsequent 10 min) the respective 
agonist administration. Each neuron served as its own control when drug effects were evaluated. 
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Event detection was performed using the Clampfit module of the PClamp 10.4 software (Molecular 
Devices Co.).  Group data were expressed as mean ± SEM and percentage change in the frequency 
of the PSCs due to the application of various drugs was calculated. Statistical analyses were carried 
out using Prism 3.0 (GraphPad Software, Inc., GraphPad). In E2-related experiments statistical 
significance was analyzed using Kruskal-Wallis test followed by Dunns post-test for comparison of 
groups. In GLP-1-related experiments statistical significance was analyzed using one-way ANOVA 
followed by Newman-Keuls post-test. We considered as significant at p < 0.05 (i.e. 95% confidence 
interval). 
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RESULTS RELATED TO THE ESTRADIOL EFFECT  
DURING NEGATIVE FEEDBACK 
Experiments concerning negative estrogen feedback period were carried out on adult, gonadally 
intact, metestrous female mice. During this gonadal stage, the concentration of the estradiol is the 
lowest in the blood and the negative feedback effect of estradiol takes place.  
Estradiol significantly decreases the firing rate and frequency of spontaneous and 
miniature postsynaptic currents in GnRH neurons of metestrous female mice 
I examined the effects of E2 on GnRH neurons of metestrous female mice using loose-patch 
experiments. In line with the original findings of Chu et al. [100], E2 at low physiological 
concentration (10 pM) diminished the action current firing activity of GnRH neurons (Figure 6.).  
 
 
Figure 6. Effect of estradiol on the action current firing 
of GnRH neurons of metestrous female mice (a 
representative recording). Application of 10 pM E2 resulted 
in a significant decrease in the frequency of the action 
current firing on GnRH neurons. Arrowhead shows the 
onset of E2 administration. 
 
 
Positive correlation between the firing rate and the frequency of GABAergic PSCs in GnRH neurons 
has been well established in the literature [64, 101, 132, 152], suggesting that a decrease similar to 
the one observed in firing might be found in PSCs. Whole-cell patch clamp method was used to 
investigate the action of E2 on sPSCs in GnRH neurons. In our experiments, the mean stochastic 
change in the frequency of the non-treated “responding” GnRH neurons was 83.7±3.8% which was 
used later as control value for the statistical analysis. Administration of E2 at 10 pM concentration 
resulted in a significant decrease in the sPSCs in 9 of 18 of examined GnRH neurons (49. 6±7.6% 
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of the baseline value 1.2±0.4 Hz; p<0.05) (Figure 7. A, C), whereas no change in amplitude of the 
sPSCs was observed suggesting role of a presynaptic process. E2 decreased the frequency of sPSCs 
within 1-2 minutes indicating that this phenomenon was due to the rapid, non-genomic effect of E2.  
 
 
Figure 7. Effect of estradiol on the spontaneous and miniature postsynaptic 
currents of GnRH neurons of metestrous female mice. (A) E2 at low physiological 
concentration (10 pM) significantly decreased the frequency of the sPSCs with no 
change in the mean amplitude. One-minute-long periods of the recording before and 
after application of E2 are depicted u  nder the recording. (B) E2 (10 pM) also decreased 
the frequency of the mPSCs, while the amplitude did not change. Representative  
zoomed intervals of the recording show the difference between the control vs. treated 
periods. (C) Bar graph summarizing the percentage changes in the frequency and the 
amplitude of the sPSCs and mPSCs resulted from E2 treatment. Arrowhead shows the 
onset of E administration. *p<0.05 as compared to the mean of stochastic control. 
 
This result raised the question whether the effect of E2 on GnRH neurons is direct or indirect. To 
examine this, mPSCs were recorded in the presence of TTX (660 nM) to inhibit propagation of 
action potentials during whole-cell patch clamp recording. The main excitatory mediator of fast 
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synaptic transmission on GnRH neuron is GABA via GABAA receptor (GABAA-R) and the 
recorded mPSCs observed under the circumstances used in our experiments were exclusively 
GABAergic [50, 152, 167, 168, 197]. Furthermore, our experiments showed that picrotoxin (100 
μM) eliminated the mPSCs, demonstrating that the recorded mPSCS are GABAergic via GABAA-
R (not shown). Administration of E2 at low physiological concentration (10 pM) resulted in a 
significant decrease in the mean frequency of the mPSCs in 8 of 12 examined GnRH neurons. 
Frequency of the mPSCs declined to 50.7±9.6% (compared to the baseline value 2.2±0.4 Hz; 
p<0.05) (Figure7. B, C), while amplitude of the mPSCs showed no significant change (Figure 7. C, 
Table 2.). These results suggest that the effect of E2 is direct on GnRH neurons of metestrous female 
mice. 
Table 2. Changes in spontaneous and miniature postsynaptic current amplitude on 
GnRH neurons. Table shows the mean amplitude before drug administration and the 
percentage change in this parameter resulted from the drug administrations . 
 
 
Amplitude 
(control; pA) 
 Amplitude change      
(% of the control) 
sPSCs E2 -37.0±5.0 104.7±3.6 
mPSCs 
E2 -31.6±3.0 102.4±5.3 
Faslodex (non-selective ER 
antagonist) + E2 
-27.8±2.4 103±2.2 
AM251 (CB1 inverse agonist) + E2 -24.7±2.2 101.3±3.5 
THL (DGL inhibitor) + E2 -30.0±4.3 93.8±3.4 
DPN (selective ERβ agonist) -36.6±6.7 102.9±5.1 
PHTPP (selective ERβ antagonist)   
+ E2 
-26.6±3.0 100.1±4.0 
AM251 (CB1 inverse agonist) + 
DPN (selective ERβ agonist) -32.7±10.6 97.1±6.0 
PPT (selective ERα agonist) -28.7±3.1 98.7±6.7 
G1 (selective GPR30 receptor 
agonist) 
-33.0±2.6 98.8±2.2 
 
The direct rapid effect of estradiol requires estrogen receptor beta 
Since the administration of E2 at low physiological concentration (10 pM) resulted in a significant 
decrease in the sPSCs and the mPSCs of GnRH neurons, we were curious about the receptor 
involved in this signaling. Our primary candidates were the estrogen receptors. To demonstrate 
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involvement of the ERs in the action of E2 on GnRH neurons, the non-selective ER antagonist 
Faslodex (1 µM) was used in the presence of TTX. After E2 application, in the presence of Faslodex, 
the mean frequency of mPSCs (84.1±4.0% of baseline value 0.5±0.1 Hz; n=6) was significantly 
higher (p<0.05) compared to the value measured with E2 alone (Figure 8.). The amplitude did not 
change during the treatments (Table 2.). This result indicated that E2 acts via estrogen receptor(s) 
in this rapid effect.  
 
 
Figure 8. Effect of estradiol on the miniature postsynaptic currents of GnRH neurons in 
the presence of non-selective estrogen receptor antagonist. (A) Pretreatment of the brain 
slice with the non-selective ER antagonist Faslodex (1µM) inhibited the effect of E2 (10 pM) 
on the mPSCs. One-minute long periods of the recording before and after application of the 
agonist are illustrated under the recordings. (B) Bar graph summarizing the percentage 
changes in the frequency and the amplitude of the mPSCs resulted from E2 treatment in the 
presence of non-selective ER antagonist Faslodex. Inhibition of the effect of E2 could be 
achieved with antagonizing the ERs. Arrowhead shows the onset of E administration. *p<0.05 
as compared to the control; **p<0.05 as compared to the change evoked by the sole E2 
treatment. 
 
The action of E2 at low physiological concentration was rapid as the effect occurred within minutes, 
suggesting the activation of intracellular signaling pathways via membrane-associated estrogen 
receptors [85, 86, 88]. ERα and ERβ have already been shown to have plasma membrane coupled 
forms besides nuclear type ones. Alternatively, GPR30 could also be the source of the rapid 
signaling events  [85, 87]. In order to identify which receptor(s) is/are involved in the mediation of 
E2 effect on GnRH neurons, we used subtype-selective ER agonists. We began the investigation 
by examining the putative involvement of ERβ as it is the most-known ER in GnRH neurons [112, 
115-117]. The subtype-selective ERβ agonist DPN (and all other ER agonists in the subsequent 
experiments) was used at the same 10 pM concentration. DPN significantly decreased the mean 
frequency of the mPSCs in GnRH neurons (60.6±5.1% compared to the baseline value 2.1±0.6 Hz; 
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n=8; p<0.05) (Figure 9. A, E). The attenuating effect of E2 was significantly abolished (73.0±6.1% 
of baseline value 0.6±0.1 Hz; n=7; p<0.05) in the presence of the specific ERβ antagonist PHTPP 
(1 µM) (Figure 9. B, E). These results indicate that ERβ activation is required for the observed 
rapid effect of E2 in GnRH neurons.  
 
Figure 9. The effect of subtype-selective estrogen receptor agonists and antagonists 
on the miniature postsynaptic currents in GnRH neurons of metestrous female 
mice. (A) The subtype-selective ERβ agonist DPN (10 pM) significantly decreased the 
frequency of mPSCs. (B) Pretreatment of the brain slice with the selective ERβ receptor  
antagonist PHTPP (1µM) inhibited the effect of E2 (10 pM) on mPSCs. (C) The selective 
ERα agonist PPT (10 pM) was unable to modify the frequency of mPSCs in the recorded 
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GnRH neurons. (D) Similarly, the GPR30 receptor agonist G1 (10 pM) did not modify 
the frequency of the mPSCs. (E) Bar graph summarizing the percentage changes in the 
frequency and the amplitude of the mPSCs resulted from selective ER agonists and 
various antagonists. The E2 and the selective ERβ agonist DPN significantly decreased 
the frequency of mPSCs. Effect of E2 could be inhibited by antagonizing selectively the 
ERβ by PHTPP. The selective ERα agonist PPT and the GPR30 receptor agonist G1 had 
no significant effect on the frequency of mPSCs. The amplitude of the mPSCs presented 
no change in any of the treatments. One-minute long periods of the recording before and 
after application of the agonist are illustrated under the recordings. Arrowhead shows 
the onset of E administration. *=p<0.05 as compared to the control; **=p<0.05 as 
compared to the change evoked by E2 treatment. 
 
In contrast, the subtype-selective ERα agonist PPT, had no significant effect on the frequency of 
mPSCs in GnRH neurons (78.7±6.4% of baseline value 2.3±1.2 Hz; n=7; p>0.05) (Figure 9. C, E). 
Similarly, the application of the GPR30 selective agonist G1 (10 pM) could not exert any significant 
change on the frequency of the mPSCs (86.0±3.5% as compared to the baselined value 0.3±0.1 Hz; 
n=5; p>0.05) (Figure 9. D, E). These data show that ERα and GPR30 have no role in mediating the 
observed rapid effect of the E2 on GnRH neurons during the negative feedback period.  There was 
no change in the amplitudes during any of the ER agonist treatments (Table 2.). 
Retrograde endocannabinoid signaling is involved in estradiol-triggered decrease of 
miniature postsynaptic currents 
Our laboratory has previously shown that endocannabinoid release from GnRH neurons could 
influence presynaptic neurotransmission to GnRH neurons [152]. Thus, the putative role of the 
retrograde endocannabinoid signaling mechanism was tested in the mediation of the effect of E2 on 
GnRH neurons by the CB1 inverse agonist AM251 (1 µM). Pretreatment of the slice (10 min) with 
this inverse agonist attenuated the decreasing effect of E2 on the frequency of mPSCs (86.9±3.5% 
of baseline value 0.8±0.2 Hz; n=5; p<0.05) on GnRH neurons (Figure 10. A, D), supporting the 
hypothesis that endocannabinoids were indeed involved in E2-evoked decrease of mPSC frequency. 
Two main types of physiological ligands for the cannabinoid receptors are known in the central 
nervous system: anandamide and 2-AG. To identify which type of endocannabinoid is involved in 
the acute GnRH neurons, tetrahydrolipstatin (THL) was used. THL is the selective inhibitor of 
diacylglycerol lipase, the synthesizing enzyme of 2-AG. THL (10 μM) was applied intracellularly 
via the patch pipette and this pretreatment diminished the effect of E2 on the frequency of mPSCs 
(88.3±2.0% of baseline value 0.7±0.2 Hz; n=5; p<0.05) (Figure 10. B, D.), indicating that 2-AG 
synthesized by GnRH neurons was involved in the action of E2. The amplitude of the sPSCs and 
mPSCs presented no change in any of these treatments (Table 2.). 
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To strengthen our findings regarding the relationship between E2 and endocannabinoid systems, 
ERβ agonist DPN (10 pM) was used in the presence of AM251. The CB1 inverse agonist also 
attenuated the action of DPN on mPSCs (82.5±2.6% compared to the baseline value 1.0±0.3 Hz; 
n=5) (Figure 10. C, D). These results support the idea that retrograde endocannabinoid signaling 
mechanism is involved in the effect of E2 suppressing GnRH activity when low physiological 
concentration of estradiol is used.  
 
Figure 10. Effect of estradiol and DPN on the miniature postsynaptic currents of 
GnRH neurons in the presence of endocannabinoid receptor/synthesis blockers.  (A) 
Effect of E2 on the mPSCs was abolished by the pretreatment with CB1 inverse agonist 
AM251 (1µM). One-minute long periods of the recording before and after application of 
the agonist are illustrated under the recordings. (B) Inhibition of the effect of E2 on the 
mPSCs could be achieved with intracellularly applied DAG lipase inhibitor THL (10µM). 
(C) ERβ agonist DPN (10 pM) had no significant effect on the frequency of mPSCs in the 
presence of AM251. (D) Bar graph summarizing the percentage changes in the frequency 
and the amplitude of the mPSCs resulted from E2 treatment in the presence of AM251 
and THL. E2 significantly decreased the frequency of mPSCs. Inhibition of its effect could 
be achieved with antagonizing the CB1 receptors or blocking the intracellular 2-AG 
endocannabinoid synthesis. Effect of the ERβ agonist DPN was eliminated by the 
pretreatment with CB1 inverse agonist AM251.The amplitude of the mPSCs did not 
change in any of the treatments. Arrowhead shows the onset of E administration. *p<0.05 
as compared to the control; **p<0.05 as compared to the change evoked by E2 treatment.  
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RESULTS RELATED TO THE GLP-1 EFFECT IN GnRH NEURONS 
In this chapter of the results, I show the effect of glucagon-like peptide-1 on GnRH neurons. To 
avoid the confounding effects of ovarian hormone changes during the estrous cycle, the experiments 
were performed on adult, gonadally intact, male mice. During our experiments, we used Exendin-4 
which is a proven and widely used GLP-1 agonist [176-178].  
The GLP-1 agonist Exendin-4 increases the firing rate and the frequency of miniature 
postsynaptic currents of GnRH neurons via GLP-1 receptor 
The GLP-1 receptor agonist Exendin-4 on the function of GnRH neurons was studied by measuring 
the action current firing. Loose patch recordings revealed that spontaneously not firing - so-called 
“silent” - GnRH neurons (approximately 25 % of all GnRH neurons) could not be influenced by 
Exendin-4 administration, hence they were discarded from the subsequent analyses.  
 
Figure 11. Effect of GLP-1 receptor agonist Exendin-4 on the firing of 
GnRH neurons of male mice. (A) Exendin-4 (1 μM) increases the firing rate 
in GnRH neurons. (B) Pretreatment of the brain slice with the GLP-1 receptor 
antagonist Exendin-3(9-39) (1 μM) inhibits the effect of Exendin-4 on firing. 
Arrowheads show application of Exendin-4.  
 
All the firing GnRH neurons recorded were burst-type neurons. In these neurons Exendin-4 (1 µM) 
increased the mean firing rate to 434.2±69.9% of the control (n=10; p<0.05) (Figure 11. A, Table 
3). Note that the effect of Exendin-4 was washed out within about 10 minutes (Figure 11. A). 
Compared to the control the average number of spikes within a burst increased to 162.3±32.9% 
(from 3.2±0.2 to 5.2±0.2; p<0.05), burst frequency increased to 381.1±65.2% (from 0.07±0.03 Hz 
to 0.2±0.02 Hz; p<0.05), and intraburst frequency increased to 172.4±54.7% (from 6.2±0.7 Hz to 
10.7±0.5 Hz; p<0.05. Lower concentrations of Exendin-4 (100-500 nM) caused no significant 
change in the average firing rate (Table 3.). In contrast, a higher dose (5 µM) evoked a robust 
increase in the firing rate (Table 3.). Therefore, the 1 µM concentration was used in all subsequent 
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experiments, in accordance with the doses used in other laboratories on other types of hypothalamic 
neurons [176].  
 
Table 3. Changes in firing rate in GnRH neurons upon Exendin-4 administration at 
various concentrations of this agonist. The first column contains firing rate before any drug 
administration (basal firing rate), the second and third columns provide change in Hz and 
percentage in firing rate after the single bolus agonist administration. *p<0.05.  
 
Dose 
Basal firing rate 
(Hz) 
After agonist Exendin-4 
in Hz in % 
Ex-4 (100 nM) 0.57 ± 0.19 0.68 ± 0.22 121 ± 52.6 
Ex-4 (500 nM) 0.50 ± 0.27 0.59 ± 0.23 118 ± 45.3 
Ex-4 (1 µM) 0.52 ± 0.23 2.25 ± 0.18 434 ± 69.9* 
Ex-4 (5 µM) 0.61 ± 0.31 3.91 ± 0.22 642 ± 57.1* 
 
 
To test the involvement of GLP-1 receptor the brain slices were pretreated with the GLP-1R 
antagonist Exendin-3(9-39) (1 µM). No alteration in the basal firing rate was observed. 
Nevertheless, this pretreatment fully eliminated the effect of Exendin-4, the mean firing rate showed 
no change (98.3±8.1% of the control; n=10; p<0.05) (Figure 11. B). Burst parameters showed no 
change either.  
A positive correlation between the firing rate and the frequency of mPSCs in GnRH neurons has 
already been proven [64, 101, 132, 152], and since Exendin-4 increased firing rate, loose-patch 
measurements were followed by whole-cell patch clamp recordings. The effect of Exendin-4 was 
further investigated by examining its action on the mPSCs, administration of Exendin-4 (1 µM) 
resulted in a significant increase in the mean mPSC frequency in all GnRH neurons studied, 
reaching 240.7±30.4% of control values (n=10; p<0.05) (Figure 12. A, D). Elevation of the 
frequency started to disappear after the 10 minutes washout period. Amplitude of the mPSCs 
however showed no significant alteration (Table 4.). Pretreatment of the brain slice with the 
antagonist Exendin-3(9-39) (10 min) caused no change in the basal mPSC frequency but abolished 
the Exendin-4 evoked frequency increase (Figure 12. B, D) providing evidence for involvement of 
the GLP-1R in the signaling (102.4±13.6 % of the control; n=11; p>0.05).  
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Figure 12. Effect of GLP-1R agonist and antagonist on the miniature 
postsynaptic currents in GnRH neurons of male mice. (A) Exendin-4 (1 μM) 
increased the frequency of the mPSCs with no change in the mean amplitude. (B) 
Effect of Exendin-4 on the mPSCs was abolished by the pretreatment with Exendin-
3(9-39) (1 μM). (C) Exendin-4 was unable to modify frequency of mPSCs when G-
proteins were intracellularly blocked by GDP-β-S (2 mM) in the recorded GnRH 
neuron. (D) Bar graph reveals that Exendin-4 significantly elevated the frequency of 
mPSCs. This effect could be inhibited by Exendin-3(9-39) pretreatment. Full 
inhibition could be achieved by antagonizing the GLP-1 receptor. The amplitude of 
the mPSCs did not change in any of the treatments. One-minute-long periods of the 
recording before and after application of Exendin-4 are drawn under the recordings. 
Arrowheads show application of Exendin-4. *p<0.05. 
 
GLP-1R is a member of the G-protein-coupled receptor family, thus the G-protein blocker GDP-β-
S is supposed to inhibit the function of the receptor. GDP-β-S was applied intracellularly to exert 
its effect exclusively in the recorded GnRH neuron, without affecting surrounding cells. To prove 
the direct action of Exendin-4 in GnRH neurons, its effect on the mPSCs was further examined in 
the intracellular presence of the GDP-β-S (2 mM). Intracellular application of GDP-β-S caused no 
change in the amplitude (Table 4.) but eliminated the effect of the GLP-1R agonist Exendin-4 on 
the frequency of the mPSCs (108.0±12.0% of the control; n=10; p<0.05) (Figure 12. C, D).  
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Table 4. Changes in miniature postsynaptic currents amplitude on GnRH 
neurons.  The table shows the mean amplitude before Exendin-4 administration 
and the percentage change in these parameters resulted from the various 
antagonists or inhibitors. 
 
 Amplitude 
(control; pA) 
Amplitude 
change               
(% of the control) 
Ex3(9-39) (GLP-1R antagonist) -41.2 ± 6.2 96.8 ± 11.5 
L-NAME (nitric oxide synthase inhibitor) -35.4 ± 7.6 102.2 ± 12.2 
AM251 (CB1 inverse agonist) -32.2 ± 8.8 100.4 ± 11.6 
L-NAME (nitric oxide synthase inhibitor) + 
AM251 (CB1 inverse agonist) 
-39.6 ± 6.7 99.3 ± 8.7 
GDP-β-S (G-protein inhibitor) -35.0 ± 6.1 93.7 ± 9.3 
CPTIO (nitric oxide scavenger) -42.5 ± 5.5 110.5 ± 15.4 
intraNPLA (neuronal nitric oxide synthase 
inhibitor) + AM251 (CB1 inverse agonist) 
-43.1 ± 7.0 106.4 ± 12.3 
L-NAME (nitric oxide synthase inhibitor) + 
AMG9810 (TRPV1 antagonist) -43.3 ± 7.0 106.1 ± 12.3 
NPLA (neuronal nitric oxide synthase inhibitor) 
+ PF3845 (anandamide degrading enzyme 
inhibitor) 
-40.4 ± 5.9 95.4 ± 8.9 
 
 
RT-PCR experiment was used to examine the expression of the Glp1r in the GnRH neurons of adult 
male mice. In addition to Gnrh1 mRNA (cycle threshold value of 24.5±0.8), expression of Glp1r 
mRNA was detected in pooled, patch pipette-harvested GnRH-GFP neuron cytoplasm samples at 
Ct 32.7±0.4. The cycle threshold value of Gapdh was 22.3±0.1 (Figure 12.). None of the transcripts 
were detected in the negative control samples. Thus, the RT-PCR confirmed the expression of Glp1r 
genes in GnRH neurons of mice. 
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Figure 13. Expression of Glp1r mRNAs in GnRH neurons harvested by patch electrodes 
for single-cell qPCR. Real-time qPCR amplification of Gnrh, Gapdh, and Glp1r cDNA from 
GnRH neurons. Expression of Glp1r transcript was detected in 2 of 3 pools of GnRH neuronal 
cytoplasmic samples. The abundance of the Glp1r was low, indicated by its relatively high 
cycle threshold values (32.5 and 33.1) as compared to the housekeeping gene Gapdh (22.0-
22.5). Column charts are in the insert to show quantitative results of the qPCR experiments.  
 
Nitric oxide and 2-arachidonoylglycerol signaling mechanisms are involved in the 
action of Exendin-4 on GnRH neurons 
Activation of the nitric-oxide system could increase the frequency of the GABAergic mPSCs in 
hypothalamic neurons suggesting that NO could be one of the candidates playing role in the effect 
of Exendin-4 [198]. Therefore, the involvement of this mechanism in the elevation of mPSC 
frequency after Exendin-4 application in GnRH neurons was examined. Slices were pretreated with 
nitric oxide synthase inhibitor L-NAME (100 µM, 10 min). This pretreatment alone caused no 
alteration in the amplitude (Table 4.). In the presence of L-NAME Exendin-4 was still able to 
increase the frequency of mPSCs to 144.5 ± 16.0% of the value measured prior to Exendin-4 
application without affecting the amplitude (Figure 14. A, D). This percentage value was, however 
significantly lower (n=12; p<0.05) than the value obtained with Exendin-4 alone. Furthermore, full 
elimination of the Exendin-4 effect could not be achieved. The percentage elevation differed not 
only from the change observed in the absence of L-NAME, but also from the value when Exendin-
4 was administered in the presence of GLP-1R antagonist (p<0.05).  
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Figure 14. The effect of Exendin-4 could be partially inhibited by blocking retrograde 
signaling pathways. (A) Effect of Exendin-4 (1 μM) was eliminated only partially when 
slices were pretreated with the NO-synthase inhibitor L-NAME (100 μM). (B) Partial 
inhibition was observed when the NO-scavenger CPTIO (1 mM) was applied intracellularly 
in the GnRH neuron. (C) Similar partial inhibition was observed in the case of pretreatment 
with CB1 inverse agonist AM251 (1 μM). (D) Bar graph reveals that Exendin-4 significantly 
elevated the frequency of mPSCs. Blockade of either the NO or the endocannabinoid system 
resulted in partial inhibition only. The amplitude of the mPSCs did not change in any of these 
treatments. One-minute-long periods of the recording before and after application of 
Exendin-4 in the presence of L-NAME are drawn under the recording. Arrowheads show the 
onset of Exendin-4 administration. *p<0.05. 
 
NO is widespread in the nervous system and it is synthesized on demand and cannot be stored as it 
is membrane permeable. To determine the cellular source of NO we dissected this regulatory 
mechanism further by applying the NO-scavenger CPTIO (1 mM) intracellularly in the GnRH 
neuron. Pretreatment of CPTIO alone exerted no effect on the amplitude and frequency values of 
GnRH neurons (Table 4.). However, after pretreatment of CPTIO, administration of Exendin-4 
increased the frequency of the mPSCs to 153.3±20.0% of the value measured before agonist 
application (n=12; p<0.05), although it was still significantly lower than in the absence of CPTIO 
(p<0.05) (Figure 14. B, D). Although intracellular scavenging of NO by CPTIO only partially 
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attenuated the excitatory effect of Exendin-4, these results suggest that NO is synthetized by GnRH 
neurons. As the partial blockade by CPTIO was very similar to the effect of L-NAME we presumed 
that another pathway should act in parallel to the NO system. This result suggested the involvement 
of other signaling pathway(s) as well. 
Previous work of our laboratory showed that tonic 2-AG release from a GnRH neuron could 
influence synaptic transmission to itself [152]. To examine whether modulation of this tonic 
endocannabinoid release was also involved in the effect of Exendin-4, the CB1 inverse agonist 
AM251 (1 µM) was applied on slice preparations. In accordance with our earlier results [152], 
blockade of the retrograde endocannabinoid signaling machinery elevated the basal mPSC 
frequency without affecting the amplitude (Table 4.), nevertheless, it attenuated but not eliminated 
the effect of Exendin-4 (Figure 14. C, D). The frequency of mPSCs was raised by Exendin-4 to 
153.1±17.1% of the value recorded before Exendin-4 application. This percentage increase is 
significantly lower (n=11; p<0.05) that measured in the absence of AM251. 
Similarly to the inhibition of the NO-release by L-NAME or intracellular scavenging of NO by 
CPTIO, the blockade of CB1 by the administration of AM251 did not fully eliminate the action of 
Exendin-4. Since the blockade of NO-production or the presynaptic CB1 could only partially inhibit 
the effects of Exendin-4 we tested the simultaneous blockade of both pathways. 
Presence of both AM251 and L-NAME in the aCSF fully abolished the effect of Exendin-4 
(102.2±12.8%; n=10, p<0.05) (Figure 15. A, D). This result suggests the simultaneous participation 
of both NO and endocannabinoid retrograde signaling mechanisms in GLP-1 signaling. 
In order to confirm our results, the specific nNOS inhibitor NPLA was applied intracellularly (1 
µM) in the extracellular presence of AM251 (1 µM) and then effect of Exendin-4 was examined on 
the mPSCs of GnRH neurons. The pretreatment alone elevated frequency of the mPSCs due to the 
inhibition of the tonic 2-AG release without affecting the amplitude (Table 4.). Simultaneous 
application of NPLA and AM251 fully abolished action of Exendin-4 on the frequency of mPSCs 
(104.8±6.1 % of the value before Exendin-4 was added, n=9, p<0.05; Figure 15.  B, D), verifying 
that GnRH neuron was indeed the source of the released NO.  
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Figure 15. The effect of Exendin-4 can be completely inhibited by the 
simultaneous blockade of retrograde systems. (A) Full blockade of action of 
Exendin-4 could be accomplished by simultaneous blockade of the NO- (by L-
NAME, 100 μM) and endocannabinoid (by AM251, 1 μM) signaling mechanisms. 
(B) Full inhibition was also achieved when nNOS was inhibited by the 
intracellularly applied NPLA (1 μM) and the endocannabinoid pathway was 
blocked by AM251 (1 μM). One-minute-long periods of the recording before and 
after application of Exendin-4 in the presence of the antagonists are drawn under 
the recordings. (C) The NO-donor L-arginine (1 mM) elevated frequency of the 
mPSCs. (D) Bar graph reveals that simultaneous blockade of the two retrograde 
systems abolished the effect of the GLP-1 agonist Exendin-4 on the mPSCs in 
GnRH neurons of male mice. The increased mPSC frequency resulted from L-
arginine confirms the involvement of the NO system in the effect of GLP-1. The 
amplitude of the mPSCs did not change in any of the treatments. Arrowheads show 
the onset of Exendin-4 or L-arginine administration. *p<0.05. 
 
The effect of nitric oxide in GnRH neurons has been examined by further experiments. The NO-
donor L-arginine (1 mM) was applied in the aCSF and resulted in the elevation of frequency of 
mPSCs (164.3±15.1%; n=10; p<0.05) (Figure 15. C, D) with no change in the amplitude (Table 4.). 
In addition, RT-PCR confirmed the expression of Nos1 genes in GnRH neurons of mice. 
Amplification curves showed that GnRH neurons expressed Nos1 mRNA (cycle threshold 
29.5±1.5) (Figure 16.). Presence of Nos1 transcript was detected in 5 out of 11 GnRH cytoplasmic 
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samples harvested from GnRH neuros. The cycle threshold value of the housekeeping gene Gapdh 
was 23.3±0.3.  
 
Figure 16. Expression of Glp1r and Nos1 mRNAs in GnRH neurons harvested 
by patch electrodes for single-cell qPCR. Real-time qPCR amplification of Gnrh, 
Gapdh, and Nos1 cDNA from GnRH neurons. Expression of the Nos1 gene in 
individually harvested glial fibrillary acidic protein (GFAP)-negative GnRH neuronal 
samples. The logarithmic scale of Rn and number of PCR cycles are indicated on the 
Y and X axes, respectively. The onset of the exponential phase (Ct) is indicated by 
horizontal lines for each target gene. Column charts in the inserts show quantitative 
results of the qPCR experiments. 
 
The retrograde 2-AG pathway is regulated by anandamide-TRPV1 signaling 
The involvement of the TRPV1 in the inhibition of 2-AG production and in the retrograde 
endocannabinoid signaling mechanism in hippocampal neurons was previously shown [156]. 
Hence, the hypothetic role of TRPV1 in the decreased tonic 2-AG production in GnRH neurons was 
examined. The TRPV1 antagonist AMG9810 (10 µM) was applied intracellularly in the presence 
of L-NAME. The amplitude did not change (Table 4.), but the effect of Exendin-4 on the frequency 
of mPSCs was completely abolished (106.0±9.8%; n=12, p<0.05) (Figure 17. A, C). 
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Figure 17. GLP-1R signaling involves the anandamide-TRPV1-coupled mechanism. 
(A) Simultaneous blockade of NOS by L-NAME (100 μM) and intracellular inhibition 
of the TRPV1 receptor by AMG9810 (10 μM) in GnRH neuron abolished the effect of 
Exendin-4. (B) Inhibition of both nNOS by NPLA (1 μM) and anandamide degradation 
by PF3845 (5 μM) resulted in full elimination of action of Exendin-4. (C) Bar graph 
summarizes these results. The amplitude of the mPSCs did not change in any of the 
treatments. Arrowheads show the onset of Exendin-4 administration. *p<0.05. 
 
Anandamide is an endogenous ligand of TRPV1. Thus, we investigated its role in the activation of 
TRPV1 by inhibiting FAAH (degrading enzyme of anandamide). The FAAH inhibitor PF3845 (5 
µM) was applied intracellularly whereas the NO signaling was blocked by the nNOS inhibitor 
NPLA (1 µM). Under these conditions the amplitude showed no change (Table 4.) but the 
stimulatory effect of Exendin-4 on the mPSC frequency was fully eliminated in GnRH neurons 
(101.0±4.3%; n=10, p<0.05) (Figure 17. B, C).  These data indicate that suppression of 2-AG 
endocannabinoid signaling is mediated by the anandamide-TRPV1 pathway. 
Finally, effect of Exendin-4 on the resting membrane potential was examined (Figure 18.). The 
measurements showed no significant change in this parameter demonstrating that ion channels 
contributing to the level of Vrest are not involved in the process. 
 
 
Figure 18. Effect of Exendin-4 on the resting membrane 
potential. Exendin-4 (1 μM) does not affect resting membrane 
potential (Vrest) in GnRH neurons. Arrow shows onset of the 
Exendin-4 application. 
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DISCUSSION 
GnRH neurons are indispensable in the central regulation of reproduction. The function of these 
neurons is influenced by a number of factors, including sex steroids, circadian rhythm, stress and 
metabolic states. During my work, my goal is to give a more accurate picture about the role of the 
gonadal steroid, estradiol and the metabolic hormone, GLP-1 in the regulation of GnRH neurons 
using electrophysiological methods. 
First part of the present dissertation demonstrates that the suppressive effect of estradiol on 
GABAergic neurotransmission on GnRH neurons requires the activation of ERβ and 2-AG 
signaling in metestrous female mice. The specific results include, (1) the firing rate and frequency 
of spontaneous and miniature postsynaptic currents significantly decrease upon estradiol treatment, 
(2) ERβ is required for the execution of this direct and rapid effect of estradiol, and (3) retrograde 
2-AG endocannabinoid signaling has an integral role in the estradiol-evoked suppression of mPSC 
frequency of GnRH neurons. 
Estradiol suppresses the firing rate and frequency of postsynaptic currents in GnRH 
neurons in metestrous female mice 
Our experiments revealed the inhibitory effect of low physiological dose of E2 on the firing rate 
and the GABAergic neurotransmission on GnRH neurons. These results are consistent with earlier 
findings, which showed that estradiol at 10 pM concentration reduced the firing of GnRH neurons 
in the absence of ionotropic GABA and glutamate receptor inhibitors [100]. The suppressive effect 
of E2 has also been reported in other cell types of the hypothalamus and other brain regions. For 
instance, estradiol suppressed the neurokinin-B agonist induced firing rate in KNDY 
(kisspeptin/neurokinin-B/dynorphin-containing) neurons of the hypothalamic arcuate nucleus [114] 
and E2 also inhibited spontaneous firing activity in extrahypothalamic regions, such as the lateral 
habenula [199].  
Additionally, our results showed that E2 administration decreased the frequency of the GABAergic 
postsynaptic currents of GnRH neurons in metestrous female mice. Similar effects of estradiol have 
been demonstrated in other brain regions: hippocampal CA1 neurons showed decreased 
postsynaptic current frequency upon estradiol treatment [200] and estradiol induced reduction of 
mPSC frequency was observed in kisspeptin neurons of the arcuate nucleus [201]. Our results are 
in line with previous findings, suggesting positive correlation between firing rate and frequency of 
postsynaptic currents in GnRH neurons [64, 101, 132]. 
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According to a recent study, chronic E2 administration has no effect on ionotropic GABA and 
glutamate receptor synaptic transmission on GnRH neurons neither in negative nor in positive 
feedback [202]. This discrepancy between these and our results may arise from usage of two 
different experimental animal models. They used gonadectomized and estradiol replaced animals in 
order to mimic  the negative and positive feedback periods, respectively [202]. On the contrary, we 
used intact metestrous mice model. The advantage of our model is the intact ovarian signaling 
mechanisms and the physiological concentration of estradiol in the blood circulation. Ovariectomy 
abolishes the natural estradiol signaling and ceases production of numerous other hormones which 
are indispensable for proper operation of HPG axis, such as progesterone, activin, inhibin, and anti-
Müllerian hormone. In agreement with our present results it has been reported that the E2 
diminished the firing of GnRH neurons which effect was arrested by the blockade of GABAergic 
and glutamatergic neurotransmission [100, 101]. These results show the essential role of the fast 
synaptic transmission in the action of estradiol on GnRH neurons. 
Estrogen receptor beta is required for the direct, rapid effect of estradiol on GnRH 
neurons 
Experiments using autoradiography combined with immunocytochemistry have not been able to 
detect the presence of estrogen receptors in GnRH neurons until the 1990s [203]. Certain neuron 
sets innervating GnRH neurons expressed nuclear ERα [10, 109, 114]. These observations were the 
basis of the general view that the function of GnRH neurons is regulated by estrogen via estrogen-
sensing interneurons (expressing ERα) located in hypothalamic and several extrahypothalamic loci. 
The discovery of ERβ [204] led to the finding that ERβ was expressed in GnRH neurons both in 
rodents [112, 115, 116] and humans [117]. Since then numerous studies have demonstrated that 
estrogen has a direct effect on GnRH neurons [86, 88, 89, 96, 100]. My doctoral thesis extended 
these studies by examining the direct effect of E2 on GnRH neurons of metestrous female mice.  
Administration of low physiological concentration of E2 onto the brain slices resulted in a 
significant decrease in the mean frequency of the mPSCs on GnRH neurons within few minutes, 
indicating that the observed effect of E2 was direct on these neurons. This effect was inhibited by 
the administration of the non-selective estrogen receptor antagonist Faslodex, suggesting the 
involvement of estrogen receptor(s) in this rapid effect. The intracellularly applied 2-AG 
endocannabinoid synthesis blocker THL eliminated the effect of E2 on mPSCs, also confirming that 
indeed the effect of E2 on GnRH neurons was direct. The action of E2 was observed within minutes 
indicating that this effect occurs via rapid non-genomic estrogen signaling, since it was detected 
much earlier and lasted significantly shorter than expected for a transcriptional mechanism of a 
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nuclear receptor. Both ERα and ERβ have membrane-associated forms, and along with other 
membrane-associated receptors such as GPR30, these mediate intracellular signaling pathways 
during the rapid action of E2 [85-88, 90, 96].  
Next, we examined the effect of various subtype-selective ER agonists to identify the ERs involved 
in the mediation of estradiol effect on GnRH neurons. The ERβ agonist DPN significantly decreased 
the mean frequency of the mPSCs in GnRH neurons. Moreover, the ERβ specific antagonist PHTPP 
also significantly blocked the suppressive effect of E2. In contrast, agonists of other membrane-
associated receptors did not show suppressive effect. Neither the ERα agonist PPT nor the GPR30 
selective agonist G1 had any significant effect on the frequency of the mPSCs on GnRH neurons. 
Taken together these results revealed the exclusive role of ERβ in the observed rapid effects of E2 
in GnRH neurons. This finding is in a good agreement with an in vivo study in which they found 
that GnRH neurons responded to estrogen in a rapid and direct manner via an ERβ-dependent 
mechanism [89]. Our experiments provided further evidence about the pivotal role of ERβ in the 
mediation of the rapid effect of E2 in GnRH neurons. 
Retrograde endocannabinoid 2-AG signaling is involved in the estradiol-triggered 
reduction of miniature postsynaptic current frequency in GnRH neurons 
Low dose of estradiol inhibited GnRH neurons in a rapid manner when the fast synaptic 
transmission was left intact [100]. This indicated the involvement of fast neurotransmission in the 
rapid action of estradiol and suggested an effect upstream to GnRH neurons.  
Fast synaptic transmission on GnRH neurons is mediated via the ionotropic GABA and glutamate 
receptors. GABA neurotransmission has been implicated as one of the major signaling in the 
regulation of GnRH neurons since the early 2000s. Whereas GABA is usually an inhibitory 
neurotransmitter in the adult central nervous system, mature GnRH neurons show the unaccustomed 
character of being excited by GABA via postsynaptic GABAA-R channels in adult rodents [45, 50-
52, 167, 168]. An earlier study from our group showed that 2-AG endocannabinoid release from 
GnRH neurons was able to influence synaptic transmission to the GnRH cells, reducing the firing 
rate and the GABAergic neurotransmission via GABAA-R. Both the CB1 antagonist AM251 and 
the 2-AG endocannabinoid synthesis inhibitor THL could influence the GABAergic input of these 
cells, providing evidence that 2-AG endocannabinoid tonically inhibits GABAA-R drive onto GnRH 
neurons [152]. Therefore, the estradiol-evoked reduction in the firing rate and the frequency of the 
mPSCs in metestrous female mice may suggest the essential role of the retrograde endocannabinoid 
system in the manifestation of the suppressing effect of estradiol. This is in good agreement with a 
previous study demonstrating that release of endocannabinoids indeed regulates the function of 
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GnRH neurons [153]. Thus, our finding that both the blockade of endocannabinoid receptor and 
inhibitor of 2-AG synthesis attenuated the effect of the low physiological dose of estradiol in the 
period of negative feedback suggest the role of retrograde 2-AG signaling mechanism in the output 
of estradiol-triggered changes in the postsynaptic currents of the GnRH neuron. A study from the 
rat hippocampus strengthens our findings, in which the key role of retrograde endocannabinoid 
system was shown to be involved in the estradiol-dependent suppression of inhibitory GABAergic 
neurotransmission to CA1 pyramidal neurons [200]. Our results showed that inhibition of 2-AG 
synthesis by the intracellularly applied THL attenuated the effect of estradiol on GnRH neurons. 
This suggests that estradiol induces 2-AG synthesis in GnRH neurons. In line with this observation, 
2-AG synthesis in immortalized GnRH neurons has already been shown [205]. The mechanism we 
have now revealed is very similar to other endocannabinoid-regulated systems in the brain, 
including hypothalamus [149, 206, 207]. Our model of estradiol action on GnRH neuron is shown 
in Figure 19. Briefly, GnRH neurons synthetize and release 2-AG endocannabinoid upon estradiol 
action via membrane associated ERβ. Next, the released 2-AG diffuses to the axon terminal of a 
presynaptic GABA afferent where it activates CB1 endocannabinoid receptor. This leads to 
attenuation of GABA release into the synaptic cleft repressing the excitatory action of GABA and 
thus decreasing the electric activity of GnRH neurons. Such interaction between estradiol and 
endocannabinoid signaling mechanisms represents a novel regulatory machinery in the execution 
of the negative estrogen feedback to GnRH neurons. 
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Figure 19. Schematic illustration of the relationship between estradiol and 2-AG 
endocannabinoid signaling in GnRH neurons of the metestrous female mice. E2 
activation of ERβ causes the synthesis and release of 2-AG endocannabinoid from the 
GnRH neuron. Then, the released 2-AG binds to CB1 located in the presynaptic 
terminal of GABAergic afferents. This causes suppression of GABA release into the 
synaptic cleft and thus the attenuation of activity of GnRH neurons. The non-selective 
ER antagonist (Faslodex) or the selective ERβ receptor antagonist (PHTPP) is able to 
block the effect of E2. The CB1 inverse agonist (AM251) or the DAG lipase inhibitor 
(THL) also inhibit the signaling mechanism. Red lines represent inhibitory actions. 
Abbreviations: 17β-estradiol (E2); estrogen receptor beta (ERβ); subtype selective ERβ 
agonist (DPN); diacylglycerol (DAG); DAG-lipase (DGL); cannabinoid receptor type 
1 (CB1); CB1 inverse agonist (AM251); non-selective estrogen receptor antagonist 
(Faslodex); subtype selective ERβ antagonist (PHTPP); 2-arachidonoylglycerol (2-
AG); tetrahydrolipstatin (THL, a DAG-lipase inhibitor);, phosphatidylinositol 4,5-
bisphosphate (PIP2); inositol 1,4,5-trisphosphate (IP3); phospholipase-C (PLC); 
GABAA receptor (GABAA-R); intracellular free calcium ([Ca2+]I); voltage-gated 
calcium channel (VGCC).  
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Besides the role of E2 in negative feedback regulation of GnRH neurons, I also studied the effect 
of the GLP-1 metabolic signal molecule on these neurons. While earlier studies described the 
modulatory effect of this gut hormone on reproduction the direct effect of this peptide hormone on 
GnRH neurons has not been fully revealed so far. The second part of my dissertation shows the 
direct regulatory action of GLP-1 on GnRH neurons. Accordingly, (1) GLP-1 increased the firing 
rate and frequency of GABAergic mPSCs via GLP-1R; (2) the molecular mechanism in the 
downstream actions of GLP-1 contains two retrograde pathways: activation of NO- and suppression 
of 2-AG signaling mechanisms; (3) inhibition of 2-AG pathway is mediated via anandamide-
TRPV1 signaling. 
GLP-1 is excitatory to GnRH neurons via GLP-1 receptor 
GLP-1 receptor agonist Exendin-4 increased the firing rate of GnRH neurons and frequency of 
GABAergic mPSCs, demonstrating that GLP-1 has stimulatory effect on GnRH neurons. Elevated 
firing activity and mPSC frequency correlates well due to the excitatory nature of the GABA via 
GABAA-R in GnRH neurons [46, 152]. Similar stimulatory effect of GLP-1 was observed in the 
paraventricular nucleus, the bed nucleus of the stria terminalis and the hippocampus [208]. GLP-1 
was also shown to activate kisspeptin neurons in the arcuate nucleus directly [209].  
Regulatory effect of GLP-1 on the reproductive axis has already been proposed [143-145]. Our 
finding is strengthened by other studies showing that GLP-1 increases spike and mPSC frequency 
in hypothalamic hypocretin/orexin neurons [176]. Alteration of GABAA-R mediated synaptic 
currents by GLP-1 has also been detected in hippocampus [210], suggesting similar mechanism in 
different area. The GLP-1 receptor antagonist Exendin-3(9-39) inhibited the excitatory action of 
GLP-1 both on firing and mPSCs frequency of GnRH neurons. This suggests an essential, direct 
role of this receptor in this action. Furthermore, our RT-PCR experiments confirmed the expression 
of Glp1r genes in GnRH neurons of mice. The fact, that the intracellularly applied G-protein 
inhibitor GDP-β-S was able to attenuate the Exendin-4 triggered elevation of the mPSC frequency 
provides further evidence for the existence of functional GLP-1R in GnRH neurons. Experiments 
with the intracellularly applied NO-scavenger CPTIO, the TRPV1 inhibitor AMG9810 and the 
FAAH inhibitor PF3845 all confirm the direct action of Exendin-4 in GnRH neurons, since we could 
demonstrate that all these chemicals efficiently blocked this intracellular pathway. Thus, we 
revealed that GLP-1 agonist has direct effect on GnRH neurons besides the indirect action via 
kisspeptin neurons suggested by others  [144].  
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One of the putative sources of GLP-1 to GnRH neurons was also identified. GLP-1-immunoreactive 
(IR) fibers reached a subset of GnRH neurons in mouse samples showing the assumed role of brain-
born GLP-1. Several hypothalamic regions are innervated by GLP-1-containing fibers originating 
from the NST [211, 212]. GLP-1-IR axons also innervate brain regions where the GnRH neurons 
are located. Thus, these results support our hypothesis, that GnRH neurons receive direct inputs 
from the periphery by the gut-born GLP-1, and also receive direct/indirect inputs from the NST by 
brain-born GLP-1.  
Effect of GLP-1 is mediated partially by activation of the nitric oxide retrograde 
signaling on GnRH neurons 
Our electrophysiological results demonstrated the involvement of the NO signaling pathway in the 
Exendin-4 evoked action. The Exendin-4 increased the frequency on mPSCs in GnRH neurons, but 
this effect was partially eliminated when the NO synthesis inhibitor L-NAME was administered. 
Similar partial inhibition was observed when the membrane-impermeable NO-scavenger CPTIO 
was intracellularly applied in the GnRH neuron. These results suggest that the increased mPSC 
frequency is due to an elevated NO level at least partially. Our experiment using the NO scavenger 
CPTIO also demonstrated that the measured GnRH neuron itself was the source of NO in this effect. 
The interaction between the NO signaling mechanism and the GLP-1 action has already been 
reported in other brain areas [213, 214]. Our data indicate presynaptic stimulatory role of NO, since 
there was no change in the amplitude or rise/decay tau along with the elevated mPSC frequency. 
NO acts as retrograde messenger, and it is released from the postsynaptic cell and travels to the 
presynaptic axon terminals [215]. Similar NO-related retrograde mechanism in the hypothalamus 
has already been described [216].  
Although NO has an integral role in reproduction, its effects seem to be rather complex. Stimulated 
GnRH release was observed after NO-donor sodium nitroprusside treatment in hypothalamic 
explants [217]. Similar increased GnRH secretion was detected following L-arginine (a precursor 
of NO) administration in immortalized GnRH-producing neuronal cell line [218]. In addition, that 
immortalized cell line expressed the neuronal nitric oxide synthase [218].  
Counter to these findings, repressive effect of NO was shown on LH secretion [219]. Inhibition of 
spontaneous firing activity of GnRH neurons was observed by NO [220]. Earlier studies could not 
detect nNOS in GnRH neurons [221]. Nevertheless, our RT-PCR experiments provide evidence for 
the expression of nNOS mRNA in GnRH neurons. Furthermore, our work revealed for the first time 
the presence of nNOS protein in mouse GnRH neurons using immunoelectron microscopy. This 
result was described in our paper [222]. The different experimental design used by us may explain 
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why earlier studies – based on light microscopy – reported the absence of nNOS protein in GnRH 
neurons [159, 221]. Our electrophysiological results provided evidences for NO synthesis in GnRH 
neurons and showed its facilitatory action on presynaptic GABAergic axon terminals targeting these 
neurons. Experiments using NO-donor L-arginine provided further evidence for functional NO-
pathway in GnRH neurons since L-arginine treatment resulted in elevated mPSC frequency. 
Expression of nNOS in immortalized GnRH-producing GT1–7 neuronal cell line was also detected 
[223]. A very recent paper also proved the presence of nNOS in GnRH neurons of ewes [224] 
confirming the possibility that GnRH neurons contain nNOS. 
Previous findings showed that activation of NO inhibited the spontaneous firing of GnRH neurons 
[220]. The reason behind the discrepancy might be that different experimental conditions such as 
recording temperature (room temperature vs. 33°C) were used. Since enzymatic processes, ion 
pumps and exchanger fluxes are extremely sensitive to temperature, this might explain the 
differences. The intracellular (pipette) solution was also different between studies. Their 
measurements were carried out using low-chloride (10 mM) pipette solution [220], whereas we used 
high-chloride concentration (130 mM) intracellular solution in our experiments. This is an important 
difference, since mature GnRH neurons maintain high intracellular chloride level [45], thus our 
experimental model may mirror the physiological conditions of GnRH neurons.  
GLP-1 acts partially via retrograde endocannabinoid signaling pathway of GnRH 
neurons 
Our experiments also provide evidences for the important role of retrograde endocannabinoid 
signaling in the GLP-1 action. The endocannabinoid receptor blocker AM251 partially inhibited the 
Exendin-4 evoked elevation of the mPSC frequency on GnRH neurons. Since this treatment did not 
cause full inhibition, similarly to the effect of nNOS inhibitor L-NAME, we could come to the 
conclusion that both retrograde systems are partially involved in the GLP-1 modulated function of 
GnRH neurons. Indeed Exendin-4 action was completely eliminated by simultaneous blockade of 
NO and 2-AG signaling. Furthermore, this effect is completely mimicked by using GLP-1R 
antagonist. These results support our model and the conclusion that GnRH neuron was the source 
of not only the NO but also the endocannabinoids. As mentioned above, it has already been 
demonstrated that tonic 2-AG retrograde endocannabinoid signaling is present on GnRH neurons 
and its activation decreased the activity of the excitatory GABAergic input [152].  The results shown 
in the first part of this thesis revealed the involvement of 2-AG endocannabinoid signaling in the 
suppressive effect of estradiol on GnRH neurons. In addition, the interaction between metabolic 
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signals and 2-AG mechanism was also reported in several neurons, including GnRH cells [132, 
225].  
The 2-AG retrograde signaling inhibits GABAergic input to GnRH neurons [132, 152], however, 
Exendin-4 could stimulate these cells, even when NO signaling was blocked by L-NAME or by the 
intracellularly applied CPTIO. Thus, we can deduce that stimulation of GLP-1R results in the 
suppression of the 2-AG pathway. A recent study showed the involvement of TRPV1 in the 
inhibition of 2-AG production and in the retrograde endocannabinoid signaling mechanism [156]. 
Stimulation of GPCRs such as muscarinic acetylcholine receptors or metabotropic glutamate 5 
receptors can activate TRPV1 by elevating anandamide level [226, 227]. TRPV1 decreases the 
activity of DGL and thus 2-AG production and eventually suppressing GABAergic transmission in 
the striatum [226, 227]. These data are in line with our finding that the GLP-1R can diminish the 
tonic 2-AG suppression of the GABAergic neurotransmission to GnRH neurons via an anandamide-
TRPV1 pathway.  
The anandamide is also able to activate the CB1. Then how is it possible that the mPSC frequency 
was not reduced by anandamide, as theoretically, increased level of anandamide may indeed mimic 
2-AG effects and act on presynaptic CB1? It may be explained by that the degrading enzyme of 
anandamide (FAAH) is postsynaptic, while the degrading enzyme of 2-AG (MGL) is presynaptic  
[228] and the 2-AG concentration is 170 times higher in the brain than anandamide concentration 
[229]. In addition, the synthesizing enzyme of 2-AG (DGL) is located postsynaptically where the 
FAAH can also be found [228]. These data suggest that 2-AG is more likely to reach presynaptic 
CB1 receptors. Therefore, the anandamide could not exert a significant direct effect on the 
presynaptic CB1. Rather, postsynaptically elevated anandamide level could possibly interfere with 
the mobilization of 2-AG by decreasing DGL activity instead of acting on the presynaptic CB1. 
The nitric oxide and endocannabinoid retrograde signaling pathways are 
simultaneously involved in the effect of GLP-1 
Similar partial inhibition of Exendin-4 action was observed when the nNOS or the CB1 was 
blocked. Complete inhibition could only be achieved by blocking the two retrograde signalings 
simultaneously. These results indicate that the downstream actions of GLP-1R on GnRH neurons 
involve both pathways. Activation of GLP-1R triggers production of NO, on the other hand it 
triggers suppression of tonic 2-AG, as illustrated in Figure 20. The proposed mechanism of GLP-1 
action on GnRH neurons involves the following steps: binding of GLP-1, or its receptor agonist 
Exendin-4 to GLP-1R activates nNOS via a G-protein mediated pathway. As a result, the level of 
NO increases and it diffuses from GnRH neuron stimulating the presynaptic GABAergic input. 
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Binding of Exendin-4 to GLP-1R simultaneously induces another pathway, it suppresses the 2-AG 
synthesis via an anandamide-TRPV1-controlled pathway. The tonic endocannabinoid 2-AG release 
reduces GABAA-R drive onto GnRH neurons [152], conversely inhibition of the 2-AG synthesis 
eventually causes facilitation of GABA release from the presynaptic terminal into the synaptic cleft.  
Similar simultaneous involvement of both retrograde signaling mechanisms has already been 
observed in the hypothalamus [198]. In that study, the NO release and endocannabinoid synthesis 
simultaneously mediated the glucocorticoid-induced suppression of glutamatergic drive and the 
facilitation of GABAA-R drive onto magnocellular neurons of the rat supraoptic nucleus [198]. 
These glucocorticoid-induced events are similar but not entirely the same as those ones we have 
observed in GnRH neurons, since the glucocorticoids activated both NO and endocannabinoid 
retrograde mechanisms whereas activation of GLP-1R evoked NO release but suppressed 2-AG 
production. This difference can be explained by the special excitatory role of GABAA-R in GnRH 
neurons.  
Elevated GABAergic neurotransmission could by itself indicate the presence of a direct presynaptic 
effect of GLP-1. Nevertheless, this can be excluded, since inhibition of cannabinoid and NO 
pathways together or G-proteins in the postsynaptic GnRH neurons both blocked the action of GLP-
1 in our experiments. Our results suggest for the first time a direct postsynaptic effect of GLP-1 by 
triggering two parallel retrograde signaling mechanisms in GnRH neurons.  
The integral role of GLP-1 in the regulation of human and rodent fertility has been described [230]. 
These observations suggest that GLP-1 peptide is capable to modulate the reproductive axis. GLP-
1R KO mice are fertile [231], male mice exhibit reduced gonadal weight and female mice show 
delayed puberty [145]. Our study provided evidences for the direct effect of GLP-1 on GnRH 
neurons. This effect is mediated by the stimulation of retrograde NO and anandamide-TRPV1-
mediated 2-AG endocannabinoid signaling mechanisms providing options to fine-tune the 
reproduction-specific effects of GLP-1. 
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Figure 20. Schematic illustration of the proposed action of GLP-1 receptor signaling 
in GnRH neurons Effect of GLP-1R agonist (Exendin-4) is mediated by G-protein 
complexes which activate two retrograde signaling systems. The first one involves 
activation of nNOS, which leads to an increased NO production. Then NO diffuses from 
the postsynaptic GnRH neuron and subsequently increases the release probability and 
vesicular reuptake of GABA at the presynaptic terminal. The NO signaling was inhibited 
by the NO synthase blocker L-NAME, nNOS inhibitor NPLA or NO scavenger CPTIO. 
The second pathway is the activation of intracellular TRPV1 by anandamide. This 
suppresses the synthesis and release of 2-AG in the postsynaptic cell. It causes 
suppression of inhibition of the presynaptic GABA release. This signaling was blocked 
by FAAH inhibitor PF3845, TRPV1 antagonist AM9810, or the CB1 antagonist AM251. 
The effect of Exendin-4 was blocked by GLP-1R antagonist Exendin-3(9-39) or the G-
protein inhibitor GDP-β-S. Red lines represent inhibitory actions, blue lines depict 
excitatory actions, and dotted lines denote putative actions. Abbreviations:  glucagon-
like peptide 1 receptor (GLP-1R); adenylate cyclase (AC); G-protein subunits (Gα, Gβ, 
Gγ); diacylglycerol (DAG); DAG lipase (DGL); cannabinoid receptor type 1 (CB1); CB1 
antagonist (AM251); 2-arachidonoylglycerol (2-AG); GABAA receptor (GABAA-R); 
protein kinase A (PKA); neuronal nitric oxide synthase (nNOS); L-NAME, a NOS 
inhibitor; NPLA, a nNOS inhibitor; GDP-Beta-S trilithium salt (GDP-β-S, a G-protein 
inhibitor); Carboxy-PTIO potassium salt (CPTIO, a NO scavenger); transient receptor 
potential vanilloid 1 (TRPV1); anandamide (AEA); TRPV1 antagonist (AMG9810); 
fatty acid amide hydrolase (FAAH); FAAH-inhibitor (PF3845). 
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NEW SCIENTIFIC RESULTS 
Thesis I. Estradiol directly suppresses the activity of GnRH neurons during the negative 
estrogen feedback period 
Low physiological dose of estradiol significantly decreases the firing rate and the frequency of 
spontaneous and miniature postsynaptic currents of GnRH neurons in metestrous female mice.  The 
decrease in frequency occurs within minutes indicating that the effect of estradiol was rapid on these 
cells. 
Thesis II. Execution of direct, rapid effect of estradiol requires ERβ in GnRH neurons during 
the negative feedback period 
Electrophysiological experiments demonstrated that the beta type of estrogen receptor is mandatory 
for the observed rapid action of estradiol on GnRH neurons, since the subtype-selective ERβ agonist 
significantly decreased the mean frequency of the miniature postsynaptic currents. In addition, the 
effect of estradiol was significantly attenuated in the presence of the specific ERβ antagonist. In 
contrast, our data showed that other membrane-associated estrogen receptor agonists (ERα, GPR30) 
had no effect in mediating the observed rapid effect of the estradiol on GnRH neurons during the 
negative feedback period. 
Thesis III. Retrograde endocannabinoid signaling is involved in the estradiol-evoked decrease 
of activity of GnRH neurons in the negative feedback period 
We have proven the interaction between estradiol and endocannabinoid signaling mechanisms in 
GnRH neurons. The retrograde endocannabinoid signaling was blocked by cannabinoid receptor 
type 1 inverse agonist and by arresting of the synthesis of 2-arachidonoylglycerol which diminished 
the estradiol-triggered changes in GnRH neurons. The relationship between estradiol and 
endocannabinoid systems was confirmed when ERβ was not effective during the blockade of 
cannabinoid receptor type 1. These results support the view that 2-arachidonoylglycerol is 
synthetized in GnRH neurons and involved in the effect of estradiol suppressing GnRH activity 
under low physiological concentration of estradiol is used.  
Thesis IV. The GLP-1 is excitatory to GnRH neurons via GLP-1 receptor 
The potent GLP-1 receptor agonist significantly increased the firing activity and the postsynaptic 
current frequency of GnRH neurons. The blockade of GLP-1 receptor by a specific antagonist could 
antagonize these effects. Furthermore, GLP-1 receptor mRNA was also detected in GnRH neurons. 
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These results demonstrate the stimulatory effect of GLP-1 and the existence of functional GLP-1 
receptors in GnRH neurons. 
Thesis V. Nitric oxide and 2-arachidonoylglycerol signaling mechanisms are involved in the 
action of GLP-1 on GnRH neurons 
Electrophysiological results revealed the involvement of NO retrograde signaling in the GLP-1-
evoked action. NO synthase inhibitor or the intracellular scavenging of NO attenuated the excitatory 
effect of GLP-1 only partially. We demonstrated the expression of neuronal NO synthase mRNA in 
GnRH neurons. These results suggest that NO is synthetized by GnRH neurons. In addition, 
application of an NO-donor elevated the frequency of the postsynaptic currents, showing the 
mediating role of the NO system in function of GnRH neurons. Our results also demonstrate the 
involvement of 2-arachidonoylglycerol signaling mechanisms in GLP-1 action, since blockade of 
cannabinoid receptor type 1 partially eliminates the action of GLP-1. Nevertheless, the effect of 
GLP-1 was fully abolished by simultaneous blockade of both pathways. These results prove the 
simultaneous participation of NO and endocannabinoid retrograde signaling mechanisms in GLP-1 
signaling. 
Thesis VI. The retrograde 2-arachidonoylglycerol pathway is regulated by anandamide-
TRPV1 signaling in GnRH neurons 
We showed that stimulation of GLP-1R results in suppression of 2-arachidonoylglycerol 
endocannabinoid pathway. GLP-1 was unable to exert its 2-AG-related stimulatory effect when both 
the TRPV1 and the NO synthesis were inhibited. The role of anandamide in the activations of 
TRPV1 was also demonstrated in our experiments. These data indicate that suppression of 2-AG 
endocannabinoid signaling is mediated by the anandamide-TRPV1 pathway. 
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